Pandora Report: 3.25.2022

We’re back! We kick off this issue with a very special update from the Bulletin of the Atomic Scientists before getting into the Bipartisan Commission on Biodefense’s recent meeting discussing the future of biodefense and biosecurity, more updates, and a number of great new publications and events to attend. We also included a brief update on why we were away last week, featuring plenty of photos of animals to brighten everyone’s day. A list of resources, updates, and faculty media features regarding Russia’s WMD disinformation is also at the end of this issue following our normal announcement section.

Has the Bulletin of the Atomic Scientists Gone Rogue?

According to the Onion, America’s Finest News Source, our friends at the Bulletin of the Atomic Scientists are demanding a whopping $10 trillion in unmarked bills, otherwise they will set their Doomsday Clock to midnight, destroying the Earth. Dr. Rachel Bronson, President and CEO of the Bulletin, was definitely quoted saying, “Citizens of Earth, we have long served as stewards of your puny globe, safeguarding it from destruction with our Doomsday Clock, and today we demand you recognize our sacrifice with a simple monetary donation—say, $10 trillion?” in a message to all UN member states. She continued with, “Since time immemorial, we overseers at the Bulletin have been responsible for averting countless catastrophes with this all-powerful timekeeping instrument, and now we ask: Will you be the generation that allows humanity to be extinguished for a measly few trillion dollars? You have heard our demands. My finger is already on the minute hand. Now what shall you do?” The Onion also reported in 2016 that the Bulletin moved the clock to 60 seconds to midnight, the closest it has ever been to global catastrophe, following Arby’s threats to create a three-cheese jalapeno beef’n bacon melt. The clock currently sits at 100 seconds to midnight because of factors like “negative trends in nuclear and biological weapons, climate change, and a variety of disruptive technologies—all exacerbated by a corrupted information ecosphere that undermines rational decision making,” so they really took the beef’n bacon melt to heart.

North Korea Conducts First ICBM Test Since 2017

Japan’s Defense Ministry announced yesterday that a new type of intercontinental ballistic missile (ICBM) from the DPRK (Democratic People’s Republic of Korea) landed in Japan’s exclusive economic zone. North Korea has not conducted such a test since 2017, during the “fire and fury” days of the Trump administration. Japanese State Minister of Defense Makoto Oniki told the press the missile likely was in the air for approximately 71 minutes before landing about 150 km west of the Oshima Peninsula off Hokkaido, Japan’s northernmost major island. The missile was later confirmed to be a Hwasong-17, which is thought to be 82 feet long and is estimated to be the largest road-mobile ballistic missile system in the world. North Korea revealed the Hwasong-17 at a military parade in October 2020, with this week’s test launch from an airport near Pyongyang being its first full-range test, according to ABC News. Kyodo News cited an unnamed source in the Japanese government who claimed this might be the closest a DPRK missile has ever come to the Japanese mainland. Prime Minister Fumio Kishida, currently attending a meeting with G7 leaders in Brussels, strongly condemned the launch and stated he would seek to work with G7 members in formulating a response to the test that violates UN Security Council resolutions. While Kim Jong Un declared a moratorium on testing nuclear weapons and ICBMs in 2018, he appeared to rescind it last January in instructing officials to “rapidly examine the issue on resuming” such testing, according to NK News. A likely new ICBM base was discovered earlier this year in Hwapyong-gun, just 25 km from the Chinese border in the north of the country, further indicating the moratorium was likely terminated. DPRK state media released propaganda videos dramatizing the massive missile’s launch, one of which quickly drew attention online for its over-the-top style (at 1:08 in the linked video). Korean Central News Agency (the state agency of the DPRK) announced this test was guided by Kim Jong Un in pursuit of a “powerful tool for nuclear attack” aimed to “contain” the United States.

Biodefense Students Conduct Vector Surveillance in Kenya for Spring Break

Biodefense Program students Michelle Grundahl (MS Student) and Danyale C. Kellogg (PhD Student and Managing Editor of the Pandora Report) recently returned from a trip to the Mpala Research Centre outside of Nanyuki, Kenya. On this trip, they assisted researchers working on grants under the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP) and the Remote Emerging Disease Intelligence Network (REDI-NET). Grundahl explained some details of the trip, saying “Our focus was to support Mason professor, Dr. Von Fricken. His work in Kenya involves surveillance of vector-borne diseases using a One Health approach. Starting on day one, we had the opportunity to collect water and soil samples, leeches, and ticks…The 10 students on this trip were intensely involved in setting up laboratory equipment and working through protocols to support the REDI-NET surveillance program.” The pair were joined by a number of Kenyan scientists who are also involved with the project through the Smithsonian’s Global Health Program. Grundahl and Kellogg previously attended the Medical Management of Chemical and Biological Casualties course, offered by USAMRIID and USAMRICD, together in the fall of 2021.

Meeting of the Bipartisan Commission on Biodefense- The Biological Threat Expanse: Current and Future Challenges to National Biodefense

The Bipartisan Commission on Biodefense met on Tuesday to discuss the expanding landscape of current and future biological threats, the roles and responsibilities of the federal government in assessing and preparing for various biological threats, and biological weapons, bioterrorism, and biological arms races with the public. The Commission explains, “In its 2015 bipartisan report, A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts, the Commission described biological threats to the Nation and made 33 recommendations to optimize U.S. efforts to prevent, deter, prepare for, detect, respond to, attribute, recover from, and mitigate intentionally introduced, accidentally released, and naturally occurring biological events. Seven years later, the U.S. experience with COVID-19 continues to validate our original findings and the need for an Apollo Program for Biodefense as biological threats to the Nation continue to expand and increase.”

Biodefense Program Director, Dr. Gregory Koblentz, also testified during this event, providing insight on the future of biodefense (time stamp- 3:47:22). On the risks posed by dual use research of concern and effective biosafety and biosecurity risk management, Koblentz concluded: “Whether or not the current pandemic was caused by a laboratory accident, it does not mean the next pandemic won’t be. Indeed, efforts to prevent and prepare for the next pandemic, ironically, include a range of activities that serve to increase the risk posed by an accident. Given that existing national and international systems to ensure that such research is conducted safely, securely, and responsibly are already inadequate, we need a new global architecture for biorisk management that can address the growing challenges we face in this domain.” The event recording is available here.

Omicron Subvariant BA.2 Updates

The BA.2 subvariant, AKA “stealth Omicron,” of COVID-19, which spreads up to 80% faster than the original Omicron variant, was found to have doubled in the US over the last two weeks, making it the dominant subvariant in the country right now, according the CNBC. Dr. Anthony Fauci told ABC News this week that BA.2, which was already dominant in some European countries, is 50% to 60% more transmissible than Omicron. The University of Minnesota’s CIDRAP noted that, “Currently BA.2 makes up roughly one third of COVID-19 cases in the United States but will likely overtake Omicron this spring,” in an article from March 21. “When you look at the cases, they do not appear to be any more severe and they do not appear to evade immune responses either from vaccines or prior infection,” Fauci said. The WHO announced too that BA.2 has taken over as the dominant strain circulating globally. The Food and Drug Administration also announced on March 21 that the Vaccines and Related Biological Products Advisory Committee will meet on April 6 to discuss boosters in light of Pfizer and Moderna’s submissions for EUAs for fourth doses of their COVID-19 vaccines.

Armed Services Committees’ Leadership Announces Selections for National Security Commission on Emerging Biotechnology

The leadership of the of the House and Senate Armed Services Committees announced their appointments to the National Security Commission on Emerging Biotechnology, which was established by Sec. 1091 of the National Defense Authorization Act (NDAA) for Fiscal Year 2022 (FY22). The National Security Commission on Emerging Biotechnology will conduct a thorough review of how advances in emerging biotechnology and related technologies will shape current and future activities of the Department of Defense, provide an interim report to the President of the United States and the Armed Services Committees within one year, and submit a final unclassified report within two years to the President and the committees, including recommendations for action by Congress and the federal government. Twelve appointed members will make up the Commission.

The leaders of the Armed Services Committees named the following appointees: Senator Alex Padilla, the Honorable Dov S. Zakheim (Senior Advisor at CSIS and former Undersecretary of Defense), Congressman Ro Khanna, Paul Arcangeli (current Staff Director of the House Armed Services Committee, set to retire on April 1), Senator Todd Young, Dr. Alexander Titus (former  Assistant Director for Biotechnology within the Office of the Under Secretary of Defense for Research & Engineering), Congresswoman Stephanie Bice, and Dr. Jason Kelly (co-founder and CEO of Gingko Bioworks).

SARS-CoV-2: International Investigation Under the WHO or BWC

Drs. Mirko Himmel and Stefan Frey recently published their policy brief article in Frontiers in Public Health discussing current debates about the origin of SARS-CoV-2 and the complexities of the political and biological elements of this debate. They offer recommendations for potential courses of action under the World Health Organization’s umbrella and in respect to the Biological Weapons Convention. They provide insight to how a number of complex issues might be resolved, particularly as China continues to delay the investigation into the start of the COVID-19 pandemic by withholding evidence.

UNIDIR- Potential Outcomes of the Ninth BWC Review Conference

The UN Institute for Disarmament Research’s recently released this report authored by Dr. Jez Littlewood. It aims to provide “a forthright assessment of the risks, benefits, and financial implications of four different potential Review Conference outcomes,” including very limited, status quo, forward-looking, and negotiation outcomes. It was released in preparation for the Ninth Biological Weapons Review Conference, currently scheduled for August of this year, where States parties will have the opportunity to advance biological disarmament and determine the future course of this treaty. The UN Office for Disarmament Affairs recently released this primer on the BWC too, covering the history of negotiations of the treaty, its current state, and the importance of this treaty in the modern world.

“Insidious Insights: Implications of Viral Vector Engineering for Pathogen Enhancement”

Biodefense Graduate Program Director, Dr. Gregory Koblentz, and co-authors recently published this article in Gene Therapy. In it they discuss the dangers of optimizing viral vectors and their properties, despite the benefits this would provide to clinical gene therapy. They write, “High potential for misuse is associated with (1) the development of universal genetic elements for immune modulation, (2) specific insights on capsid engineering for antibody evasion applicable to viruses with pandemic potential, and (3) the development of computational methods to inform capsid engineering.” They ultimately recommend that “…computational vector engineering and the publication of associated code and data be limited to AAV [(adeno-associated viruses)] until a technical solution for preventing malicious access to viral engineering tools has been established.”

CSIS Global Health Policy Center Coronavirus Crisis Update

The Center for Strategic and International Studies’ Global Health Policy Center recently released a new episode of its podcast, Live From Munich: Dr. Richard Hatchett “Pandemic Preparedness Needs to Be Viewed as a Security Challenge”. Dr. Hatchett reminds listeners that having just had a pandemic does not prevent outbreak of another, and that pandemic preparedness needs to be “viewed as a security challenge, not as a health challenge, not as a development challenge”. He points to lessons in vaccine manufacturing and financing arrangements that incentivize disease surveillance that can better prepare us for the next pandemic. “Many of the high-income countries see the value from a geopolitical and security perspective in making these investments. The challenge for the long term, obviously, will be whether these facilities can be successful, sustainable, and be sustained.”

WHO- “Emerging Trends and Technologies: A Horizon Scan for Global Public Health”

The World Health Organization released this report earlier this month identifying 15 new and emerging technologies and scientific advances that could have major impacts on global health in the coming decades. To do so, it “presents the findings of a global horizon scan, conducted by a group of international experts, on emerging technologies and trends relevant to global public health conducted in 2020 and 2021.” Identified issues include vaccine distribution, apps for disease screening, addressing dis- and misinformation, and machine learning for antibiotic discovery. Dr. Filippa Lentzos of King’s College London recently co-authored an article addressing issues similar to the latter in Nature Machine Learning discussing the dangers of using AI in drug development.

Curious Coincidence: A Journey To the Origins of COVID-19

MIT Technology Review released a new episode of their podcast discussing challenges in determining the origins of the pandemic, this time focusing on what is known about the disease’s emergence in Wuhan in late 2019. Hosted by investigative reporter Antonio Regalado, Curious Coincidence dives into the mysterious origins of COVID-19 by examining China’s trade in wild animals, the labs doing sensitive research on dangerous pathogens, and questions of whether a lab accident may have touched off a global pandemic. Dr. Laura H. Kahn also recently discussed these issues in her piece in the Bulletin of the Atomic Scientists.

Building Public Trust in Public Health Emergency Preparedness and Response (PHEPR) Science: A Workshop

From the ongoing COVID-19 pandemic to wildfires and floods, public health emergencies are becoming increasingly common and complex. Public trust in public health emergency preparedness and response (PHEPR) science is key to a quick and effective response. Join the National Academies of Sciences, Engineering, and Medicine for a two-day public workshop on March 29th and 30th to examine issues of building public knowledge of and trust in PHEPR science enterprise–the institutions, the research process, and the researchers and practitioners. Learn more and register here.

Inaugural Public Meeting of the National Advisory Committee on Seniors and Disasters and National Advisory Committee on Individuals with Disabilities and Disasters

Join Assistant Secretary for Preparedness and Response Dawn O’Connell along with Assistant Secretary for Aging and Acting Administrator for Community Living Alison Barkoff, Wednesday, March 30 from 1:00 p.m. to 3:30 p.m. ET for the inaugural meeting of the National Advisory Committee on Seniors and Disasters (NACSD) and National Advisory Committee on Individuals with Disabilities and Disasters (NACIDD). Advanced registration for this meeting is required and can be accessed, along with additional meeting information, through the online event page. During this joint meeting, committee members will be sworn into service and begin a national discussion with federal subject matter experts on the challenges, opportunities, and priorities in meeting the unique health needs of older adult populations and people with disabilities during and after disasters and public health emergencies.

WHO Outreach and Engagement Consultant Job Opening Announcement

The purpose of this consultancy is to provide technical  input related to the projects of the emerging technologies, research prioritization and support (EPS) unit on dual-use research of concern as part of the “Reducing Biological Proliferation Risks Posed by Dual Use Research of Concern – (DURC)” and end to end research process optimization as part of the project “Strengthening WHO processes to accelerate timelines linking R&D with access”. The work will advance the implementation of the corresponding work plans of the two projects. Due to the COVID restrictions, the consultant will perform the work remotely from his/her home location. The consultant will need to be available during Geneva office hours (9h00-18h00 CET). Learn more and apply here.

Russian WMD Disinformation Resources

The mountain of debunkings and academic commentary on the Russian disinformation campaign targeting DTRA’s Biological Threat Reduction Program-supported labs in Ukraine continues to grow. Below are some highlights from the last couple of weeks:

Have You Been Lied to About Ukrainian Biolabs? 

Drs. Filippa Lentzos and Gregory Koblentz recently hosed this even on Twitter Space discussing the ongoing bioweapon claims targeting labs in Ukraine. A recording of the event is available here and the transcript can be found here.

Defense Threat Reduction Agency

DTRA has released this fact sheet discussing its support for Ukrainian labs and other key facts, including details of Russia’s illegal and dangerous takeover of multiple Ukrainian-owned labs. They have also released a YouTube video discussing the program and the beneficial work it has done and continues to do in disarmament and public health.

Peace Research Institute Frankfurt

The PRIF Blog published this piece explaining and refuting Russia’s BW claims while also addressing concerns that these claims could be used as a pretext for a chemical weapons attack against Ukraine. Read more here.

Council on Strategic Risks

Francesco Femia and Caitlin Werrell at CSR authored a piece, “The Deeply Dangerous Spread of Russian Disinformation on Biological Weapons,” discussing the implications of Russia’s debunked claims. Of the idea that Russia might use WMDs in this war, they quote Andrew Weber, former Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs, writing “If Russia does commit such atrocities, “There would be a very strong and united international response to any use of chemical or biological weapons, both of which are banned by the chemical and biological weapons conventions,” Andy Weber emphasized.”

Nuclear Threat Initiative

Hayley Severance and Jacob H. Heckles with NTI’s Global Biological Policy and Programs team explained some of the dangers of this Russian propaganda, focusing on the division and confusion it sows and the potential for this to later allow Russia to be viewed as justified in their invasion and war against Ukraine. Check out the piece, “Russian Propaganda Established a Dangerous, Permissive Environment,” here.

Congressional Research Service

CRS, the public policy research institute of the United States Congress, released a CRS Insight addressing members’ of Congress questions and concerns regarding these laboratories. It discusses the dangers combat operations pose to these facilities and potential courses of action Congress might consider taking as a result of these issues.

CBW Events Ukraine FAQ Page

CBW Events has created a one-stop-shop for all your questions on this issue here. CBW Events is “a project to create a record of events to enable and encourage understanding of how policies on the issues relating to chemical and biological warfare and its prevention are developed.”

Dr. Gregory Koblentz Was Recently Quoted in Numerous Outlets Discussing These Claims

Dr. Koblentz has been working overtime taking interviews to help combat this disinformation. Below are some of the quotes he provided within the last couple of weeks across various news outlets and debunking sites.

Daily Mail– “The 46 US Labs in Ukraine and the $200 Pentagon Program That Sparked a Propaganda War: How Ex-Soviet Facilities Adopted by America That House Pathogens Prompted Kremlin Bioweapons Claims in Putin’s Back Yard”

  • “‘These are all public health and veterinary labs,’ said Gregory Koblentz, director of the Biodefense Graduate Program at George Mason University, according to Poynter. ‘None of them have been involved in biological warfare’.” 

The Washington Post– “A Legacy of ‘Secrecy and Deception’: Why Russia Clings to an Outlawed Chemical Arsenal”

  • “Novichok’s distinctive chemical formula differed from that of other known nerve agents, and because of this, Novichok was initially omitted from the Chemical Weapons Convention’s list of banned substances. Russia could thus continue to tinker with the new weapon without technically violating their treaty obligations, said Gregory Koblentz, a biological and chemical weapons expert and director of the Biodefense Graduate Program at George Mason University’s Schar School of Policy and Government.”
  • ““Russia didn’t just inherit the Soviet chemical weapons arsenal; they also inherited the secrecy and deception that surrounded the program,” Koblentz said.”

Axios Science “Why Allegations of Chemical Weapons Use Are Hard to Investigate”

“What to watch: Gregory Koblentz, director of the Biodefense Graduate Program at George Mason University, says that, rather than use a chemical or biological weapon for an attack in Ukraine, there is a risk “Russia will invent or stage an event, claim it as an atrocity and use it domestically for escalating their commitment to the conflict.”

  • “Even if the U.S. and Ukrainians could expose this was staged or a hoax, on some level, the disinformation would be out there, and some would throw up their hands and say they don’t know and are going to sit it out,” he says.
  • Another concern for Koblentz is that unsubstantiated claims that bioweapons are being developed in Ukrainian labs that study and surveil pathogens like Crimean hemorrhagic fever could damage international cooperation on biosecurity and pathogen surveillance among labs around the world.

What’s next: The BCW is scheduled to meet in August to discuss how its mechanisms for resolving concerns about biological weapons compliance could be strengthened.

  • There had been signs over the past few years that parties may be willing to agree to measures that would facilitate verifying whether parties are complying. But “now there is no way it will be a constructive diplomatic event,” Koblentz says. “It’s been sacrificed for geopolitics.””

Bloomberg Quicktake– “Ukraine: Is Russia Planning to Use Weapons of Mass Destruction?”

iNews– “How Russia’s Fake Claims About Ukraine Bioweapons Spread From Telegram Anti-Vaxxers to Fox News”

  • ““It goes back to the 1980s, when the KGB started a rumour that the United States occurred the HIV virus,” said Dr Greg Koblentz, Deputy Director of the Biodefense Graduate Program at George Mason University.”

CNN What Matters– “Russia and Chemical Weapons: What You Need to Know”

  • Dr. Koblentz featured heavily in this article through a long interview discussing many facets of Russian CBW, including the difference between BW and CW, Russia’s obligations under international law, the potential for Russia to use such weapons against Ukraine, and more

Open– “No! Quelli in Ucraina Non Sono Laboratori Militari Per La Guerra Biologica” (Italian: “No! The Labs in Ukraine Are Not Biowarfare Labs”)

  • “Associate professor and director of the Biodefense Graduate Program at Mason University’s Schar School of Policy and Government , Gregory Koblentz, explains to Open why the Russian narrative of biological weapons laboratories in Ukraine could be the first phase of a maneuver aimed at attributing to the A completely invented biological threat was born.”
  • “These laboratories are used to diagnose and conduct research on endemic diseases in Ukraine – explains Koblentz -, they are not designed or intended for use to conduct research on biological weapons. The concern is not whether Russia will take them over and use them to develop biological weapons. Moscow already has three large military microbiology facilities which it uses to conduct research and development on biological weapons. Instead, the concern is that Russia is leaking “evidence” fabricated in those labs and claiming to have uncovered a secret US-Ukraine program to develop biological weapons. Of course, such a statement would be nonsense.”
  • “The only way these laboratories could pose a danger would be if they were bombed, looted or occupied and unsuspecting individuals accidentally became infected with a leftover pathogen sample – continues the expert -, which was on site but no longer properly stored. . The WHO has told Ukraine to destroy the samples of high-risk pathogens in their laboratories for this reason ”.
  • “The United States and Ukraine have been transparent about the type of public health research conducted in these laboratories – concludes Koblentz -, as you can see on the US embassy website . The Defense Department has just released a new fact sheet explaining its assistance to Ukraine in this area. The BTRP strengthens biological health and safety in laboratories around the world and develops the capacity of these laboratories to diagnose and study diseases that pose a threat to public health in those countries. Since the onset of COVID-19, the program has also helped these countries respond to the pandemic by providing diagnostic kits, etc. “

EFE Verifica– “Nada Prueba Que Haya Laboratorios de Armas Biológicas en Ucrania, Como Afirma Rusia” (Spanish: “Nothing Prove That There Are Biological Weapons Laboratories in Ukraine, As Russia Claims”)

  • “For his part, Gregory Koblentz, director of the Biodefense Graduate Program at George Mason University’s Schar School of Politics and Government, recalls that in 1980 the Soviets spread the rumor that the US had “invented” the HIV virus and was being “used” as a biological weapon.”
  • “Since then, this type of disinformation campaign has been “quite aggressive” and has targeted not only the US, but also Georgia and Ukraine, stresses Koblentz, for whom these accusations are part “of a pattern” in propaganda Russian.”

Pandora Report: 3.11.2022

Our major focus this week is on Russia’s continued claims that the US is supporting WMD development in Ukraine, ranging from claims lodged at DTRA CTR labs to assertions the US is helping the Ukrainians make a dirty bomb and chemical weapons. Multiple organs of the US government have indicated the Kremlin may use chemical or biological weapons or create a false flag operation to justify their claims about CTR and their invasion of Ukraine. We also discuss the ODNI’s release of the Intelligence Community’s Annual Threat Assessment, which includes a dedicated health security section this year. We have also included a number of fascinating new publications, including reports on the Namhung Youth Chemical Complex in North Korea, China’s global health leadership ambitions, and a report discussing balancing protecting patients from infections and pandemic response in a hospital setting. Finally, we discuss updates on the pandemic as it remains far from over, death counts continue to soar in places like Hong Kong, and it presents an issue for Ukrainians fleeing to other countries.

Admin note: There will be no Pandora Report next week (3/18). The weekly report will resume on 3/25.

Russia Continues Its WMD Disinformation With Help As Concerns Grow About False Flag Operations

Russia’s Ministry of Foreign Affairs (MFA) and Ministry of Defense (MOD) continued their barrage of claims alleging the US is helping the Ukrainians make WMDs, this time asserting the Russian military found evidence the Ukrainians staged an emergency clean-up to eradicate “…traces of the military-biological programme, in Ukraine, financed by the [US Department of Defense].” Major General Igor Konashenkov delivered this latest claim, which was quickly parroted by state media. He claimed pathogens such as the causative agents of plague, anthrax, and cholera were being made into bioweapons in US-funded laboratories throughout Ukraine. The MFA also claimed on March 6 that the Security Service of Ukraine and Azov Battalion “mined a reactor at an experimental nuclear facility at the Kharkov Institute of Physics and Technology” in order to “accuse Russia of creating an ecological catastrophe.” The Atlantic Council noted that this claim was based on a supposed alert from the Russian MOD and was supplemented by quotes from the state-owned outlet, Sputnik.

Russian Ministry of Foreign Affair’s Tweet further alleging DTRA CTR-sponsored labs are bioweapons development facilities.

The Sino-Russian Relationship Isn’t Complicated Enough To Keep China Away From These Conspiracy Theories Apparently

Various Chinese outlets have already been sharing Russia’s narrative, however the Chinese Ministry of Foreign Affairs has more formally begun doing so as well. PRC MFA spokesperson, Zhao Lijian, made several comments at a press briefing this week accusing the US of violating the BWC at its labs in Ukraine. He accused the US of preventing multilateral verifications of these facilities from taking place before saying, “What is the real intention of the United States? What exactly has it done? These have always been the source of misgivings for the international community.” A description of DTRA’s CTR program’s accomplishments in its first 25 years is available here.

This is also not China’s first time making such claims. Throughout and following the Korean War, North Korea, the Soviet Union, and China claimed the United States used biological weapons on large scale in both China and North Korea. Though Soviet Central Committee documents indicating these claims were known to be false were declassified in 1998, both North Korea and China have continued to make these claims over the decades. As we previously covered, China has a number of nonsense claims they have made recently too, including assertions that the US engineered COVID-19 at the US Army Medical Research Institute of Infectious Diseases, that the US military introduced SARS-CoV-2 to Wuhan at the World Military Games in 2019, and even that the Omicron variant entered the country on a piece of mail from Canada.

This comes at a time when many are questioning the strength of the Sino-Russian relationship, as Xi Jinping tries to balance supporting Putin while shielding his country from the economic hardship and isolation the world has levied on Russia. It also remains unclear how much Chinese officials actually knew about Russia’s plans to invade Ukraine, though it is thought they had at least some level of advance knowledge and asked Putin to wait until after the Beijing Olympics. The two countries issued a joint statement last month, titled “Joint Statement of the Russian Federation and the People’s Republic of China on the International Relations Entering a New Era and the Global Sustainable Development”. It included a section on the BWC and claims the US is not fulfilling its obligations under the treaty, stating “The sides emphasize that domestic and foreign bioweapons activities by the United States and its allies raise serious concerns and questions for the international community regarding their compliance with the BWC.” It later stated, “The sides call on the U.S. and its allies to act in an open, transparent, and responsible manner by properly reporting on their military biological activities conducted overseas and on their national territory, and by supporting the resumption of negotiations on a legally binding BWC Protocol with an effective verification mechanism.”

Russian Outlets’ Lazy Attempts at Disinfo Somehow Still Have the Desired Effect

This all somehow managed to grow worse late this week as the US Undersecretary of State for Political Affairs, Victoria Nuland, testified before the Senate Foreign Relations Committee. Over the course of the hearing, she stated “Ukraine has biological research facilities which, in fact, we are now quite concerned Russian troops…Russian forces may be seeking to gain control of. So we are working with the Ukrainians on how they can prevent any of those research materials from falling into the hands of Russian forces should they approach.” She later stated that, should there be any of use of CBW in Ukraine, the Russians would be behind it. Russian outlets like RT and Sputnik were quick to re-share the unedited clip, which their followers concluded meant Nuland was confirming the US has biological weapons facilities in Ukraine. This was echoed by the likes of American conservative commentators Tucker Carlson and Candace Owens on their respective platforms. RT did not have to do any work to splice the clips of Nuland, create confusion about the context, or anything to get this clip spread around, viewed millions of times, and touted as proof the US was lying about having BW facilities in Ukraine. They simply played an accurate statement from the undersecretary and let their audiences do the rest. This has been a rapid progression from the situation a couple weeks ago, with Foreign Policy’s Justin Ling writing, “In less than two weeks, a conspiracy theory about Ukrainian biolabs has gone from a fringe QAnon Twitter account to becoming a major rallying cry for both Russian President Vladimir Putin’s regime and the U.S. far-right.”

In case it somehow is not clear enough already- the terms “biological research facilities” and “biolabs” do not mean the same thing as “biological weapons facilities”. A biological research facility just describes an institution or building where research is being conducted in some area of biology. Different types of hospital research labs, labs at zoos, numerous university labs, and all sorts of institutions can accurately be described as “biological research facilities”. As a result of the threat Russian forces pose to these facilities in Ukraine, the WHO advised Ukraine on Thursday to destroy high-threat pathogens from their public health labs to prevent “any potential spills” that could cause disease in the population.

Birds of Mass Destruction?

On Thursday, the Russian MOD released a video discussing the supposed results of their report about documents from “military biological activities of the USA in Ukraine”. The MOD included screenshots of various Power Point slides and materials from DTRA throughout the presentation, including an unclassified slide discussing the risk of emerging infections in insectivorous bats in Ukraine and Georgia and the need for interagency efforts to stem the threat to public health this poses. The video then makes a number of wild claims that make even some of the most ardent conspiracy theorists look comparatively poised and logically sound. Such claims include that the US wants to release migrating birds carrying highly pathogenic H5N1 influenza. Another claim is that a Project R-781 is focused on US efforts to use bats as carriers for biological weapons. This is simply non-sensical. The US does not conduct bioweapons R&D, it certainly would not need to do so in Ukraine if it wanted to, and releasing birds, bats, and insects carrying highly infectious diseases would likely harm the US as well as any intended target. It is highly unlikely the Russians believe any of this to be true and they are just using this as an attempt to keep up the pressure in their disinformation firehose and create frustrations and tensions where possible.

A Note On Biosafety Levels

Some of those re-sharing these posts from Russian outlets have also focused their attention on the biosafety levels (BSL) of the CTR labs in Ukraine, claiming they must be making bioweapons because they have certain BSL designations. Those making these claims seem to either focus on the Wuhan Institute of Virology’s BSL-4 designation, somehow concluding this means the Ukrainian labs must also be at this level and, by extension, they are making bioweapons. Others focus on the term “high containment lab”, either assuming or purposefully deceitfully claiming that term means the labs are BSL-4 labs by definition. First, Ukraine does not have a BSL-4 facility. Second, the term “high containment lab” refers to both BSL-3 and BSL-4 facilities. Third, many of these claims are based on an out-of-context clip of a chapter of a National Academies Press publication– “Biosecurity Challenges of the Global Expansion of High-Containment Biological Laboratories: Summary of a Workshop”. This specific chapter discusses local resources and regulations for high containment labs in Ukraine in which the authors discuss the differences in how Ukrainian labs are rated (lab designation in Ukraine is inverted, so 1 is the highest risk and 4 is the lowest) and why this makes it especially important to consider what specific permits Ukrainian labs have that allow them to handle certain pathogens. Furthermore, the biosafety level of a lab is not an indicator of what that facility is doing. Rather, BSLs are sets of biocontainment precautions required to work with biological agents in laboratories. They are sometimes called pathogen, protection, or containment levels, the latter of which uses the designations P1-P4 instead.

For context, BSL-4 is the highest level of precautions and is used for work with agents that can easily be transmitted as aerosols in the lab, cause severe to fatal disease in humans, and for which there are no available vaccines or treatments. Some BSL-4 agents include Ebola, Marburg, Lassa, and Nipah viruses. The other levels can vary in terms of which pathogens are handled in them depending on the conditions and the work being conducted, such as if there were a high chance an agent would become aerosolized while being worked with, which would necessitate a higher BSL. Common BSL-3 agents include SARS classic, SARS-CoV-2, MERS-CoV, Rift Valley Fever virus, and even Yersinia pestis, the bacterium that causes plague. Some examples of potential BSL-2 agents include pathogenic strains of E. coli, Hepatitits A, B, and C viruses, HIV, and even prions, which transmit diseases like Creutzfeldt–Jakob disease (the human version of Mad Cow Disease). Things like non-pathogenic strains of E. coli and different types of Staphylococcus are frequently handled in BSL-1, including in labs at secondary education institutions.

While abiding by federal law and research guidelines, different institutions in the US place different agents at different BSL levels based on their facility’s capabilities, what they plan to do with an agent, and what risks may come of such work. You can see Stanford University’s list and guidelines here, for example. The Biosafety in Microbiological and Biomedical Laboratories, the document that helps labs make protocol-driven risk assessments and determine what BSL they should work in is also freely available online

Furthermore, a BSL-4 designation does not imply the lab is government-run, and certainly does not mean it is necessarily doing offensive research. Using the US as an example, of the 13 BSL-4 labs in the US, three are housed at universities – Boston University’s National Emerging Infectious Diseases Laboratories, Georgia State University’s High Containment Core, and the University of Texas Medical Branch’s Galveston National Laboratory. Kansas State University also has its BSL-4 National Bio and Agro-Defense Facility under construction. Fewer than 1/5 of BSL-4 facilities globally are actually defense laboratories and two are even privately-owned, according to Global Bio Labs. USA Today also found a few years ago that there are around 200 BSL-3 labs (at least) in the US, meaning many Americans live near one. Meanwhile, the labs in Ukraine are below BSL-4 and they are well-established centers providing important public health research and services. In fact, the closest BSL-4s to Ukraine are the Republican Research and Practical Center for Epidemiology and Microbiology in Minsk, Belarus and two facilities in Hungary. Furthermore, the US has been open from the beginning about the purpose and scope of the Lugar-Nunn Cooperative Threat Reduction program as well. And while just one-quarter of countries with BSL-4 labs score well on best practice indicators for biosafety and biosecurity, the Lugar-Nunn program has helped ensure partner countries do meet these requirements consistently, limiting the chances of accidents.

Is This All a Set Up For a False Flag Operation? The US Government Weighs In

White House Press Secretary Jen Psaki commented on this ongoing issue on Twitter earlier in the week, stating, “We took note of Russia’s false claims about alleged U.S. biological weapons labs and chemical weapons development in Ukraine. We’ve also seen Chinese officials echo these conspiracy theories.” She re-iterated that this is something Russia and China have done repeatedly, adding that the US is in full-compliance with its obligations under the BWC and CWC. She also stated, “It’s Russia that has a long and well-documented track record of using chemical weapons, including in attempted assassinations and poisoning of Putin’s political enemies like Alexey Navalny.” She concluded with a warning that Russia might look to use chemical or biological weapons to create a false flag operation, writing, “Now that Russia has made these false claims, and China has seemingly endorsed this propaganda, we should all be on the lookout for Russia to possibly use chemical or biological weapons in Ukraine, or to create a false flag operation using them. It’s a clear pattern.”

White House Press Secretary Jen Psaki’s tweets concerning Russian allegations the US is supporting chemical and biological weapons development in Ukraine.

Finally, the US State Department also released an official statement on the Kremlin’s claims. State Department Spokesperson Ned Price’s delivered the following statement:

The Kremlin is intentionally spreading outright lies that the United States and Ukraine are conducting chemical and biological weapons activities in Ukraine.  We have also seen PRC officials echo these conspiracy theories.  This Russian disinformation is total nonsense and not the first time Russia has invented such false claims against another country.  Also, these claims have been debunked conclusively and repeatedly over many years.

As we have said all along, Russia is inventing false pretexts in an attempt to justify its own horrific actions in Ukraine. The United States does not own or operate any chemical or biological laboratories in Ukraine, it is in full compliance with its obligations under the Chemical Weapons Convention and Biological Weapons Convention, and it does not develop or possess such weapons anywhere. It is Russia that has active chemical and biological weapons programs and is in violation of the Chemical Weapons Convention and Biological Weapons Convention.

Finally, Russia has a track record of accusing the West of the very crimes that Russia itself is perpetrating. These tactics are an obvious ploy by Russia to try to justify further premeditated, unprovoked, and unjustified attacks on Ukraine. We fully expect Russia to continue to double down on these sorts of claims with further unfounded allegations.

While it remains unclear if the Russians are interested in using CBW or trying to stage a false flag operation, there are still inherent dangers to these types of weapons that dissuade actors from their use, though some still certainly do use these kinds of weapons. Furthermore, as Dr. Filippa Lentzos and Jez Littlewood pointed out in the Bulletin of the Atomic Scientists this week, this could also end up damaging the Biological Weapons Convention, set for its five-year review later this year. They also rightfully point out that the US identified a number of countries as BW threats, including the DPRK, Iran, Libya, Syria, Sudan, and Iraq, the latter of which is arguably the most infamous intelligence failure of the US this century. Few could forget the images of Secretary of State Colin Powell holding up a model vial of anthrax spores during a meeting of the UNSC on Iraq’s alleged WMD program in 2003. While this assessment was not just based on US intelligence alone, this was later something he described as a “blot” on his career, stating “I’m the one who presented it on behalf of the United States to the world, and [it] will always be a part of my record. It was painful. It’s painful now.” While the US has not been perfect, the labs under DTRA’s CTR program have demonstrated time and time again that they are legitimately conducting peaceful research and that they provide benefits to the public health of the region.

Other Helpful Resources On This Topic:

  • EUvsDisinfo released this week’s Disinfo Review, Weapons of Mass Delusion covering these efforts, finding that a quarter of Russia’s disinformation tropes pertain to the lie that the US has secret labs encircling the country.
  • Here is the page on the Biological Threat Reduction Program on the US Embassy in Ukraine’s website. Many conspiracy theorists, right-wing American pundits, and Russian outlets claim this page was taken down, yet it is still live and has all the PDFs discussing the diagnostic labs in Lviv, Kharkiv, Luhansk, Dnipro, and Vinnytsia that some insist are gone from the site.
  • Here is PolitiFact’s fact check of the first few claims in this new series lodged by Russia.

US Surgeon General Releases RFI on COVID-19 Disinformation

On a related note, to help combat the effects of disinformation in the United States, the US Surgeon General, VADM Vivek Murthy (USPHS), has issued a formal request for information to major tech companies, asking them to send data and information on the prevalence of COVID-19 mis-/disinformation on their platforms. This is part of the Biden administration’s National COVID-19 Preparedness Plan and companies will have until May 2 to comply with the RFI. Dr. Murthy also has asked healthcare professionals to submit their testimonies about how COVID-19 mis- and disinformation have impacted their patients and communities. This comes as a physician group, No License for Disinformation, and their calls for state medical board to take disciplinary action against physicians who deliberately spread misinformation about the COVID-19 pandemic gain more traction.

WHO Issues Situation Report on the Russo-Ukrainian War

As the news has been filled with reports of Russian attacks on civilians and healthcare institutions, including the bombing of a maternity ward and children’s hospital in Mariupol, the WHO has released its first situation report on Ukraine since Russia launched its invasion. The report indicates over 18 million of Ukraine’s population have been affected, including 1.2 million refugees, 160,000 internally displaced person, at least 553 civilian injuries, and 249 civilian deaths. It notes that conflict related trauma and injuries are currently exacerbated by a lack of access to healthcare facilities as well as a lack of medicine and supplies. Importantly, it also explains there is an excess of morbidity and death from common illnesses such as noncommunicable diseases (such as cardiovascular disease, diabetes, cancer, etc.) and acute maternal, newborn, and child illnesses. The spread of infectious diseases is on the rise in Ukraine as well, including COVID-19, measles, polio, TB, HIV and diarrheal diseases. This is due to widespread destruction of water and sanitation infrastructure, inadequate vaccination coverage, lack of access to medicines and medical care, safe water, adequate sanitation and hygiene as well as population movements and crowding. Ukraine faced a polio outbreak and was just pulling out of weeks of record high COVID-19 case counts when Russia invaded on 24 February. Ukraine has a relatively low vaccination rate and the government was struggling with vaccine hesitancy prior to the invasion. The WHO is continuing to monitor the situation and trying to help the Ukrainian Ministry of Health in coordinating the health response.

World Surpasses 6 Million COVID-19 Deaths As the Pandemic Drags On

The pandemic is very much not over, with the world surpassing 6.03 million official COVID-19 deaths Thursday. Worse yet, these are only confirmed deaths, with the true count likely being much higher. This horror is inescapable in places like Hong Kong right now, where the death count is continuing to soar as officials race to test all 7.5 million Hong Kongers three times this month to try and maintain the mainland’s zero-COVID strategy. Death rates also remain high in Poland, Hungary, Romania, and other Eastern European countries, which does not bode well with over 1 million Ukrainian refugees flooding in to these places. Despite this, a 136-page report written by two dozen experts, many of whom advised President Biden, was released this week entitled, “Getting to and Sustaining the Next Normal: A Roadmap to Living with Covid.” This report argues the US pandemic response should shift from being focused only on COVID-19 to focusing on a system where prevention, mitigation, and treatment efforts are focused on a number of respiratory illnesses, including influenza and COVID-19. They do stress this “next normal” will not be like 2019, but that this is how to best deal with pandemic fatigue and more diverse health threats as case counts in the US decline.

US Intelligence Community Releases Annual Threat Assessment

The Office of the Director of National Intelligence (ODNI) has released its unclassified 2022 Annual Threat Assessment of the US Intelligence Community (IC). This year’s assessment includes an entire section dedicated to health security, covering infectious diseases and the impact of the COVID-19 pandemic, biological weapons, and anomalous health incidents (AHIs). Key assessments include that the COVID-19 pandemic is likely to continue to strain health systems, possibly aiding the spread of other diseases; that countries around the world remain vulnerable to the emergence of a new novel pathogen that could cause a worse pandemic; that economic fallout from the pandemic will continue to challenge governments and hinder human development, particularly in the developing world; and that shortcomings in pandemic response may inspire adversaries to consider developing or using biological weapons.

The brief sub-section on biological weapons assesses, “Global shortcomings in preparedness for the pandemic and questions surrounding the origins of the COVID-19
virus and biosecurity may inspire some adversaries to consider options related to biological weapons developments.” It states that advances in dual-use technology like bioinformatics, synthetic biology, and genomic editing, could help enable the development of new bioweapons that are able to complicate detection, attribution, and treatment. It also addresses ongoing efforts by China, Iran, and Russia to tout their individual and collaborative efforts to improve biosecurity while also making false claims about US laboratories pertaining to the origin of COVID-19, biosafety breaches, vaccines, and bioweapons. It concludes that this messaging will likely be amplified ahead of the Review Conference of the Biological and Toxin Weapons Convention, which is held every five years and is schedule to convene in mid-2022.

The sub-section on AHIs states that, “IC agencies assess with varying levels of confidence that most reported health incidents can be explained by medical conditions, or environmental or technical factors and that it is unlikely that a foreign actor—including Russia—is conducting a sustained, worldwide campaign involving hundreds of incidents without detection.” This is in reference to reports of Havana Syndrome, a condition first reported in 2016 by US and Canadian diplomats serving in Cuba with symptoms including ringing in the ears, vertigo and nausea, and cognitive difficulties. There are a number of speculations about what caused this, including theories that the Russians are using electromagnetic energy and ultrasound to target US and Canadian personnel.

This section of the threat assessment also summarizes some of the findings of 2021’s Updated Assessment on COVID-19 Origins, indicating that four IC elements assess with low confidence that SARS-CoV-2 was a result of zoonotic spillover while one assesses with moderate confidence that it was the result of a laboratory-associated incident. The same assessment also addressed concerns the virus was a bioweapons or genetically engineered, writing “We judge the virus was not developed as a biological weapon. Most agencies also assess with low confidence that SARS-CoV-2 probably was not genetically engineered; however, two agencies believe there was not sufficient evidence to make an assessment either way. Finally, the IC assesses China’s officials did not have foreknowledge of the virus before the initial outbreak of COVID-19 emerged.”

Three reports that Nature announced in February 2022 discussing SARS-CoV-2 origins have caused quite a stir recently as well. Two of the reports traced the original outbreak of COVID-19 back to the Huanan Seafood Wholesale Market, which sold live animals, in Wuhan, Hubei Province. A third report suggests that SARS-CoV-2 did spill over from animals- potentially those at the Huanan Market- to humans at least twice in November and December 2019. These reports include genetic analyses of samples collected from the market and infected people in December 2019 and January 2020 in addition to geolocation analyses connecting many of the samples to a specific portion of the market where live animals were sold. Important to note, however, is that these are still preprints and have not yet been published in peer-reviewed journals, though some argue they do add more weight to the idea that the pandemic started at the Huanan Market despite not being definitive.

GAO’s Chris P. Currie Testifies Before Senate Committee on Opportunities to Improve National Biodefense Strategy and Implementation

The Director of Homeland Security and Justice at the Government Accountability Office, Chris Currie, testified before the Senate Committee on Homeland Security and Governmental Affairs on Opportunities to Address National Strategy and Programmatic Challenges pertaining to biodefense. His testimony addressed GAO studies in this area from December 2009 through August 2021, focused on efforts to implement the National Biodefense Strategy and strengthen biodefense preparedness, as well as ongoing challenges to DHS’s biosurveillance and biodetection efforts. Currie stated that GAO determined the US lacks “a set of defined capabilities for responding to nationally significant biological incidents, an interagency process for assessing and communicating exercise priorities, an interagency process for agencies to consistently report on the
capabilities exercised in after-action reviews, and routine monitoring at the interagency level of exercises and real-world incidents in order to evaluate lessons learned across the government, identify patterns and possible root causes for systemic challenges, and make recommendations to address these challenges.” He also discussed pathways to changing the National Biosurveillance Integration Center’s charge, DHS’s struggles to justify updating detection systems rendering it over-focused on aerosolized attacks, and how DHS can mitigate risk in Biological Detection for the 21st Century (BD21) acquisition. Read his statement and the GAO recommendations here.

Global Pandemic Preparedness Summit Sees CEPI Secure $1.5 Billion in Funding

The Coalition for Epidemic Preparedness Innovations (CEPI) secured $1.535 billion in funding over the course of the UK’s Global Pandemic Preparedness Summit this week. This is in support of CEPI’s goal of being able to produce a new vaccine for newly detected COVID-19 variants within 100 days of detection. This 100 day goal relies on accelerating global genomic surveillance to quickly identify new pandemic threats. The UK pledged $211 million, Indonesia (current G20 President) gave $5 million, and the US pledged $150 million, among other donations from other top donors including the governments of Japan, Norway, Germany, and Australia, the Bill & Melinda Gates Foundation, and Wellcome. This did not fully cover CEPI’s goal of $3.5 billion over the next five years, though it certainly puts them well on their way. According to CEPI’s statement, “CEPI’s plan will reduce the risk posed by epidemics and pandemics by developing vaccines for known disease threats (such as Lassa fever, MERS and Nipah virus), and build on the scientific advances made during COVID-19 to prepare in advance for ‘Disease X’- the threat of an unknown pathogen with pandemic potential.” Read USAID Administrator Samantha Power’s statement on the funding and push to deploy new vaccines for new COVID-19 variants within 100 days of detection here.

RUSI Occasional Paper- Remote Assessment of North Korea’s Chemical Weapons, Feasible or Not?

The Royal United Services Institute has released a new report, “Remote Assessment of North Korea’s Chemical Weapons, Feasible or Not?” discussing how open source research and remote sensing technologies might be used to assess North Korea’s CW capability. To do this, the authors use a case study approach focusing on the Namhung Youth Chemical Complex in South Pyongan Province. Their research process included gathering data and information to build a case study that could be used to test this approach, analysis and assessment of the chemical activities and determination of whether those activities have relevance for CW production, and analysis of the overlap between the signatures of chemical activity and CW specifics at the Namhung Complex, followed by examination of how remote sensing might be able to support further assessment of CW capability. They conclude that the Namhung Complex is not a site used purely for CW production, but that it does likely retain activities relevant for CW. They determine for an open-source approach to be of the most value, the method would have to be replicated across the DPRK’s chemical industry. Furthermore, they state analyses should consider CW production as a network instead of focusing too much on individual sites. They conclude that, “…while remote sensing tools will not be a silver bullet in assessing the status, scope and scale of North Korea’s CW programme, they can be used to refine hypotheses about North Korea’s CW capability.”

APIC Releases New Recommendations for Balancing Patient Safety and Pandemic Response

The Association for Professionals in Infection Control and Epidemiology (APIC) has released its new call to action, “Between a Rock and a Hard Place: Recommendations for Balancing Patient Safety and Pandemic Response, a Call to Action on Improving our National Strategy for Pandemic Preparedness and Patient Safety”. It outlines a number of recommendations and steps to implement them including: developing next-generation universal personal protective equipment; normalizing the use of masks by the general public during times of increased infectious disease threats; addressing supply chain failures, including personnel with IPC expertise on healthcare system incident command and emergency response teams; putting properly trained personnel in long-term care, nursing homes, and other high-risk settings; building and implementing infection prevention and control surge capacity; increasing capacity for testing and contact tracing; ensuring rapid data sharing and interoperability around infection surveillance data; establishing strategies and actions to build disease confidence; and funding pandemic preparedness workforce capacity training.

Biodefense PhD program alumna and current Term Assistant Professor at the Schar School, Dr. Saskia Popescu, co-authored a portion of this report, “Managing Communications During a Pandemic”.

CFR- The COVID-19 Pandemic and China’s Global Health Leadership

Dr. Yanzhong Huang, Senior Fellow for Global Health at the Council on Foreign Relations, has released this new CFR report discussing China’s attempts to gain prominence in global health leadership and opportunities for the United States to re-assert itself in this area. In it he discusses China’s earlier attempts to turn its comparative success in managing COVID-19 into taking center stage in global leadership. However, he explains that its initial mishandling of the outbreak undermined the country’s international reputation, harming its ability to project soft power and strengthen its international image. Recent developments with highly transmissible variants have also challenged China’s draconian outbreak response measures and called into questions the efficacy of Chinese vaccines. He cautions the country is also heading towards a wider immunity gap between its population and the rest of the world, writing “The zero-COVID strategy will be extremely costly and highly dangerous: a small omicron outbreak in China could quickly develop into multiple larger outbreaks across the country, sending shock waves through society and the economy and intensifying the disruption of global supply chains and inflation pressures worldwide.” He concludes with a number of recommendations for the Biden administration, urging that the US should cooperate with Beijing in this area when it is helpful (such as in disease surveillance, response capacity-building, and vaccine distribution) while also scaling up US health diplomacy efforts and forming a bloc with allies to increase the WHO’s authority. This report is available here from CFR.

Insidious Insights: Implications of Viral Vector Engineering for Pathogen Enhancement

Biodefense Graduate Program Director, Dr. Gregory Koblentz, has co-authored this new article in Gene Therapy. In it, the authors discuss how viral vector engineering offers enormous benefits, but brings a dual use risk pertaining to pathogen enhancement. They explain that optimizing viral vectors and their properties will prove important for improving the effectiveness and safety of clinical gene therapy, but there are particular risks in which reliable and generalizable methods of immune evasion could increase viral fitness, potentially causing a new pandemic. They write, “High potential for misuse is associated with (1) the development of universal genetic elements for immune modulation, (2) specific insights on capsid engineering for antibody evasion applicable to viruses with pandemic potential, and (3) the development of computational methods to inform capsid engineering.” They explain a number of ways this could be mitigated, including prioritizing non-viral delivery systems, before concluding with recommendations about how this data should be published until a technical solution for preventing malicious access to these viral engineering tools is established.  

Commemoration of the 34th Anniversary of the Chemical Weapons Attack on Halabja

March 16th, 2022 marks the 34th anniversary of the chemical attack on Halabjah. On this occasion, this event aims at commemorating all victims of chemical weapons and raising awareness about chemical weapons and chemical weapons disarmament. It is organized by Rotary Peace Fellows Alumni Association and World Beyond War. It is open to all interested individuals. Speakers are prominent activists, including Dr. Paul Walker (Coordinator of the CWC), who have worked in CW-related fields for years. Their presentations will be followed by Q&A and one minute of silence. This virtual event is on March 12 at 4:00 pm BMT. Register here.

Building Public Trust in Public Health Emergency Preparedness and Response (PHEPR) Science: A Workshop

The National Academies of Sciences, Engineering, and Medicine is hosting a two-day public workshop on March 29th and 30th to examine issues of building public knowledge of and trust in the public health emergency preparedness and response (PHEPR) science enterprise. Workshop discussants and participants will specifically:

  • Examine why the topic of public trust (and trustworthiness, credibility, confidence in, among others) is important in PHEPR science and develop a shared understanding of its importance and its relationship to other factors that contribute to social cohesion in public health emergencies.
  • Explore key elements of PHEPR science communication and generate actionable communications strategies based on recent experiences.
  • Generate actionable strategies and approaches for building/maintaining trust, communicating PHEPR science and the scientific process in the face of uncertainty and in response to the recent decline in perceived credibility of federal, state, and local agencies.
  • Examine the ways in which diverse demographic groups experience PHEPR science differently and generate strategies and approaches for building trust in PHEPR science and the scientific process that is tailored to these varied experiences.

Find more information and register here.

Open Source Technology Tools For United Nations Security Council Resolution 1540 Implementation

The Strategic Trade Research Institute (STRI) is hosting the webinar “Open Source Technology Tools for United Nations Security Council 1540 Implementation,” sponsored by the United Nations Office for Disarmament Affairs (UNODA) through voluntary contributions received from the Government of the Republic of Korea. The event will feature an expert panel discussion and demonstration of open source tools and resources available to all UN Member States that can help strategic trade stakeholders gather information, assess risks, make policy and authorization decisions, and take effective enforcement measures. Before the event, registered participants will receive links to the resources and publications that will be discussed by the event panelists. The event’s focus is on tools that are publicly accessible. The objective of the webinar is to compile use cases for these tools as well as demonstrate to Member States and their stakeholders the availability, accessibility, and value of open source instruments for strengthening UNSCR 1540. This event will be useful for both public and private sector decision-makers who play a role in  UNSCR 1540 implementation measures.

Panelists include Jason Arterburn (Program Director for State-Sponsored Threats at C4ADS), Dr. Richard T. Cupitt (Senior Fellow and Director of the Partnerships in Proliferation Prevention program at the Henry L. Stimson Center), and Peter Heine (Senior Advisor in Global Security Technology and Policy at Pacific Northwest National Laboratory). This event will occur March 23 at 10:00 AM EST. RSVP here.

From ASPR: Comments Requested on 2023-2026 National Health Security Strategy

Through a Federal Register Notice (FRN) published by ASPR on February 14, 2022, the Office of the Assistant Secretary for Preparedness and Response is soliciting public comments to provide information regarding threats and challenges to national health security, and promising practices to address the same. The information provided will be used to inform the development of the 2023-2026 National Health Security Strategy (NHSS). The NHSS is a four-year strategy that establishes a strategic approach to strengthening the country’s ability to prevent, detect, assess, prepare for, mitigate, respond to, and recover from disasters and emergencies. The upcoming iteration of the NHSS (2023-2026) presents a unique opportunity to reflect on lessons learned from the COVID-19 pandemic and focus the nation’s priorities to address evolving public health challenges and be better prepared for future health security threats. For more information, please view the full FRN posted to the Federal Register. Comments will be accepted March 25, 2022, electronically to nhss@hhs.gov with “2023-2026 NHSS Comments” in the subject line. Comments may be placed in the body of the email or in an attachment to the email using a standard document format.

Pandora Report: 12.6.2019

Are We Making Progress on the Antibiotic Resistance Front?
Antibiotic resistance is a problem that crosses sectors, industries, species, and frankly, requires a widespread effort to make a dent in the problem. Whether it be stewardship among medical providers, surveillance and rapid isolation, or use within agriculture, this is a global issue that we’re just not doing that well in. While the latest CDC report shows that annual deaths due to drug-resistant infections is decreasing since their last analysis, the number of infections occurring is still quite high. In 2013 it was reported that 2.6 million infections occur annually and in this latest report, they found that each year there are 2.8 million antibiotic-resistant infections resulting in 35,000 deaths. Moreover, the 2019 report shows 5 new urgent threats and 2 new threats, which emphasizes the role of stewardship initiatives and One Health. “But there is plenty to worry about. Though hospitals are making headway, the agency found some of the greatest increases in infections are acquired outside hospitals. Also, the threat of antibiotic resistance is remarkably fluid; new threats arise even as old ones are mitigated. For example, the CDC has raised the alert level to ‘urgent” for Candida auris, a multi-drug-resistant yeast that can cause invasive infection and death’.” At a global level, the World Health Organization (WHO) has worked to guide national action plans, which countries can employ and modify to their specified needs. Hint: we’ll be doing a spotlight on resistant fungal infections within this newsletter so make sure to keep reading.

The Mystery and the Truth Surrounding the Explosion at Vektor
Since the explosion in September, there’s been  growing conversation around what really happened at Vektor, but also the immediate media coverage that was often over-hyped and opportunistic. Dr. Filippa Lentzos has broken down the facts and ultimately, the implications of those rapid reports. Citing inspections from the WHO-led team, she notes that previously, the site had met international biosecurity and biosafety standards as a smallpox repository. While Vektor’s history includes being an offensive weapons site during the era prior to the Biological Weapons Convention (BCW) and some time after, it has been transformed to a site for research and biodefense. Truly, the biggest issue, Lentzos notes, is the biosafety issues that frequent such research. “Jens Kuhn, a German virologist who was part of a Pentagon-sponsored program that sent young scientists to work in former bioweapons labs, was the first Western scientist through the door at VECTOR in July 2001. Getting in was anything but easy, but once inside he found that contrary to fears he had heard expressed in the West, the high-containment units operated both safely and securely. ‘The Russians don’t want to kill themselves any more than Western scientists,’ Kuhn is quoted as saying in a Nature news story.” While the facility has been upgraded and repaired in recent decades, the Russian government declares biodefense activities and confidence-building measures through the BWC regularly. Sure, they’re doing research with deadly disease like Ebola and Marburg, not to mention storing smallpox, but it’s important to remember that not only is Russia following the International Health Regulations (IHR), which would require them to report risky public health events, but they also did communicate the explosion (although, mostly through the media) and that it happened in the decontamination room – an incident that did not warrant such IHR reporting. As Lentzos underscores, some of the reactions to the event were overblown but this is a prime example of why transparency during such events is critical to avoid misinformation and opportunistic reporting.

Synopsis of the Crimson Contagion 2019 Functional Exercise After-Action Review
This week, the National Biodefense Science Board convened a meeting focusing on the after-action review of the Crimson Contagion 2019 Functional Exercise, a national level exercise series conducted to detect gaps in mechanisms, capabilities, plans, policies, and procedures in the event of a pandemic influenza.  Current strategies include the Biological Incident Annex to the Response and Recovery Federal Interagency Operational Plans (2018), Pandemic Influenza Plan (2017 Update), Pandemic Crisis Action Plan Version 2.0, and CDC’s Pandemic Influenza Appendix to the Biological Incident Annex of the CDC All-Hazard Plan (December 2017). These plans, updated over the last few years, were tested by the functional exercise with emphasis on the examination of strategic priorities set by the NSC. Specifically, examined priorities include operational coordination and communications, stabilization and restoration of critical lifelines, national security emergencies, public health emergencies, and continuity. The Crimson Contagion 2019 Functional Exercise included participation of almost 300 entities – 19 federal departments and agencies, 12 states, 15 tribal nations and pueblos, 74 local health departments and coalition regions, 87 hospitals, 40 private sector organizations, and 35 active operations centers. The scenario was a large-scale outbreak of H7N9 avian influenza, originating in China but swiftly spreading to the contiguous US with the first case detected in Chicago, Illinois. Continuous human-to-human transmission of the H7N9 virus encourages its spread across the country and, unfortunately, the stockpiles of H7N9 vaccines are not a match for the outbreak’s strain; however, those vaccines are serviceable as a priming dose. Also, the strain of virus is susceptible to Relenza and Tamiflu antiviral medications. The exercise was intended to deal with a virus outbreak that starts overseas and migrates to the US with scant allocated resources for outbreak response and management, thereby forcing the Department of Health and Human Services (HHS) to include other agencies in the response. To do so, the exercise began 47 days after the identification of the first US case of H7N9 in Chicago, otherwise known as STARTEX conditions. Then, the HHS declared the outbreak as a Public Health Emergency (PHE), the World Health Organization (WHO) declared a pandemic, and the President of the United States declared a National Emergency under the National Emergencies Act. As was the case in the 1918 Great Influenza, transmissibility is high and cases are severe. At STARTEX, there are 2.1 million illnesses and 100 million forecasted illnesses as well as over half a million forecasted deaths. As the pandemic progresses along the epidemiological curve, the overarching foci of the federal-level response adjusts across four phases:

  1. Operational coordination with public messaging and risk communication
  2. Situational awareness, information sharing, and reporting
  3. Financing
  4. Continuity of operations

The outcome of the Crimson Contagion is that vaccine development is the silver bullet to such an outbreak, but there are complications beyond its formulation. Namely, the minimization of outbreak impact prior to vaccine development and dispersal, strategy for efficient dissemination of the vaccine across the country, allocation of personal protective equipment (PPE), and high expense of vaccine development and PPE acquisitions. The exercise concluded that HHS requires about $10 billion in additional funding immediately following the identification of a novel strain of pandemic influenza. The low inventory levels of PPE and other countermeasures are a result of insufficient domestic manufacturing in the US and a lack of raw materials maintained within US borders.  Additionally, the exercise revealed six key findings:

  1. Existing statutory authorities, policies, and funding of HHS are insufficient for a federal response to an influenza pandemic
  2. Current planning fails to outline the organizational structure of the federal government response when HHS is the designated lead agency; planning also varies across local, state, territorial, tribal, and federal entities
  3. There is a lack of clarity in operational coordination regarding the roles and responsibility of agencies as well as in the coordination of information, guidance, and actions of federal agencies, state agencies, and the health sector
  4. Situation assessment is inefficient and incomplete due to the lack of clear guidance on the information required and confusion in the distribution of recommended protocols and products
  5. The medical countermeasures supply chain and production capacity are currently insufficient to meet the needs of the country in the event of pandemic influenza
  6. There is clear dissemination of public health and responder information from the CDC, but confusion about school closures remains

A final report with greater detail of the after-action review of the Crimson Contagion 2019 Functional Exercise is forthcoming. Stay tuned.

Biosecurity Insight
The latest Biosecurity Insight is out, which is a great source for information from the Centre for Biosecurity and Biopreparedness (CBB) established by the Danish Parliament. In this new volume, you can read about the control of CRISPR, fake news and biological weapons (“Pathogens are impossible to see and their effects difficult to understand. This makes the fear of them a dangerous device to be exploited through fake news. In a world where more than half of the population is online, social media can become a device to spread panic and mistrust, and hamper responses to natural disease outbreaks.”), and how the internet enables bioterrorism. You can read more here.

The Nuclear Balancing Act – Energy and Security
On November 14th, the GMU Schar School of Policy and Government hosted a panel conversation on the intersection of nuclear energy and security. “Students and faculty members from the Schar School of Policy and Government, as well as representatives from government agencies and nongovernmental organizations, joined Brent Park, Deputy Administrator for Defense Nuclear Nonproliferation at the U.S. Department of Energy’s National Nuclear Security Administration, and Mikhail Chudakov, Deputy Director General for Nuclear Energy at the International Atomic Energy Agency (IAEA)” to have frank conversations about the future state of nuclear energy and how to address “energy poverty”. Moderated by GMU biodefense professor and graduate program director Dr. Gregory Koblentz, the group discussed the marriage between these two nuclear components and that we ultimately need to continue having these conversations. As Dr. Koblentz noted, “Given the growing demand for carbon-free energy and the dynamic geopolitical situation, it was very informative to hear about how the IAEA and the United States work together to promote safe and secure nuclear energy.”

Biological Weapons Convention Meeting of States Parties (MSP)
This week the MSP began, bringing together states parties engaged in the prohibition of biological weapons. You can read Richard Guthrie’s daily summaries of the meetings here or even watch the livestream on UN Web TV. Hot topics will likely include funding and the current financial state, national implementation, verification, etc. The United Nations Institute for Disarmament Research (UNIDIR) has provided a 30-page overview of compliance and enforcement in the BWC, which you can access here. Written by Filippa Lentzos “this paper takes stock of the mechanisms that are currently available for attempting to determine and ensure compliance with the Biological Weapons Convention (BWC). It presents three conceptual layers of BWC compliance: one legally binding, one politically binding, and one wholly voluntary. The paper also describes a fourth, elusive layer—the verification layer—which remains one of the fundamental challenges of biological disarmament and non-proliferation.” On day 5 of the MSP, Guthrie noted that during the science and technology meeting of experts  “there was broad agreement of a need for some form of review arrangement, but with very little detail in the discussion. In the past, for example, some delegations have favoured a small committee of experts while others have favoured some form of arrangement that would allow all states parties to contribute to it. The lack of expressions of support for specific models may be a positive sign as many delegates would seem to prefer achieving consensus on some form of review mechanism rather than pressing for their ideal.”

Missing Links – Understanding Sex- and Gender-Related Impacts of Chemical and Biological Weapons
A new report released via UNIDIR is also addressing the interest that “has grown in gender as a useful analytical perspective to examine the impact of particular means and methods of warfare. Multilateral debates on chemical and biological weapons, however, have not systematically considered the relevance of sex- and age-disaggregated data on the effects of these weapons, nor knowledge of gender dynamics, in the implementation of the Biological and Chemical Weapons Conventions (BWC and CWC, respectively).” Written by Renata Hessmann Dalaqua, James Revill, Alastair Hay, and Nancy D. Connell, this is an extremely detailed and thorough look into the sex and gender dynamics that we often fail to address when it comes to CBW. The report is broken down into several sections – like sex and gender specific effects of chemical and biological weapons, which delves into the social roles and exposure as women are often the primary caregivers, as well as the social stigma and discrimination associated with exposure. Perhaps one of the most interesting sections was on health-seeking behaviors, noting that in some areas, the potential for stigma often impacts if medical care is sought. “Evidence from South Asia, Africa, and Vietnam suggests that the potential for stigmatization affects women’s help-seeking more than men”. Overall, this report was extremely informative and helpful in understanding those roadblocks for not only accurate reporting, but also building the most effective response in the event of an attack.

Using Genome Sequencing to Combat Healthcare Outbreaks 
GMU Biodefense doctoral alum Saskia Popescu discusses how genome sequencing can change response to outbreaks in healthcare settings. Infection prevention epidemiologists work hard to identify spikes in usual case counts or rapidly respond to single cases of unusual organisms. Unfortunately, identifying a source or transmission mechanism isn’t always that easy and we often don’t find the proverbial “smoking gun”.  However, a study assessed the use of genome sequencing in real-time as a tool to help give hospital epidemiologists and infection control an advantage against microorganisms. Investigators across several universities discussed how they employed the rapid and cost-efficient tool during an outbreak of Acinetobacter baumannii at the Queen Elizabeth Hospital Birmingham in 2011. The source of the outbreak was found to be a military patient from Afghanistan who was being treated for a blast injury. This specific case is unique in that the outbreak lasted an incredibly long time—80 weeks, which is the longest ever studied for Acinetobacter baumannii. 

Antimicrobial Resistant Fungal Infections
Fungi are eukaryotic organisms like molds, yeasts, and mushrooms that can be pathogenic in humans. Antifungal medications treat dangerous fungal infections, but antifungal resistant microbes are on the rise, just like antibiotic resistant bacteria. For example, antifungal resistance is increasingly common in severe Candida (a yeast) infections, which often causes nosocomial bloodstream infections. The Centers for Disease Control and Prevention (CDC) released a report on antibiotic resistance threats in the US, which includes a warning about drug-resistant fungi as a serious public health issue. According to the report, 18 microorganisms cause three million antibiotic resistant infections and 35,000 deaths each year. This is the first CDC report to include antibiotic-resistant fungi to include Candida auris along with other resistant Candida species and azole-resistant Aspergillus fumigatus, a mold. Resistance is inherent to certain fungi but can also develop through the misuse and overuse of antifungal and antibiotic drugs in human medicine and agriculture. As with antimicrobial resistance at large, the ubiquitous use of stronger and stronger antimicrobial medications is contributing to the spread of resistance while struggling to combat ongoing infections. The CDC is taking several steps and actions to prevent and reduce resistance:

  • Tracking trends in antifungal resistance through the Emerging Infections Program (EIP)
  • Supporting a network of regional public health laboratories through the Antibiotic Resistance Laboratory Network (ARLN) to perform antifungal susceptibility testing for Candida
  • Using genetic sequencing and developing new laboratory tests to identify and study specific mutations associated with antifungal resistance in Candida
  • Summarizing antifungal prescribing patterns across different healthcare facilities to promote appropriate use of antifungals

The CDC’s warning also includes suggestions about what can be done to curb the threat of antifungal resistance:

  • Healthcare facility executives and infection control staff can:
    • Assess antifungal use as part of their antibiotic stewardship programs
    • Ensure adherence to guidelines for hand hygiene, prevention of catheter-associated infections, and environmental infection control
  • Doctors and other hospital staff can:
    • Prescribe antifungal medications appropriately
    • Test for antifungal resistance for patients with invasive disease who are not improving with first-line antifungal medications
    • Stay aware of resistance patterns, including antifungal resistance, in your facility and community
    • Document the dose, duration, and indication for every antifungal prescription
    • Participate in and lead efforts within your hospital to improve antifungal prescribing practices
    • Follow hand hygiene and other infection prevention and control guidelines with every patient

Outbreak Dashboard
More attacks have plagued Ebola outbreak response efforts in the DRC, as case counts reach 3,313. Flu activity is also continuing to grow, as B/Victoria viruses are the most common and the CDC reported 8% of respiratory specimens tested by clinical labs were positive for influenza. The CDC is continuing to advise people not to consume romaine lettuce from the Salinas, CA, growing region due to an E. coli O157:H7 outbreak.

News of the Weird
A controversial fence, African swine fever, and Danish critics. In the realm of ASF outbreak response, some are calling the latest efforts in Denmark a waste of money. “On Monday, Denmark completed the fence along the border with Germany to protect its nearly 5,000 pig farms that export 28 million pigs annually, according to the Danish Agriculture and Food Council in a DW.com article. The 1.5-meter tall and half-meter deep fence runs from the Wadden Sea in the west to the Flensburg Fjord in the east. The fence construction cost Denmark around $12 million.” From potentially disrupting migration and an impact on the ecosystem, critics are saying the real threat is the importation of contaminated swine.

Stories You May Have Missed:

Pandora Report: 10.4.2019

What’s New with Novichoks?
Gregory Koblentz, Director of the Biodefense Program, and Stefano Costanzi, a chemistry professor at American University, have published an article in The Nonproliferation Review about recent efforts to add Novichok nerve agents to the Chemical Weapons Convention’s list of Schedule 1 chemicals which are subject to the highest level of verification. Novichok become a household word after Russian agents used this new type of chemical weapon in the attempted assassination of Sergei and Julia Skripal in Salisbury, United Kingdom in March 2018, but there is still a good deal of public confusion about this family of nerve agents. In “Controlling Novichoks After Salisbury: Revising the Chemical Weapons Convention Schedules,” Koblentz and Costanzi clarify the identity of the nerve agent  used in the Salisbury incident and evaluate two proposals regarding Novichoks that will be considered by the Organization for the Prohibition of Chemical Weapons (OPCW) in November. This will be the first time the CWC’s Schedules have been revised since the  treaty was opened for signature in 1993.

Bipartisan Commission on Biodefense Cyberbio Convergence Recap & The Germy Paradox
GMU Biodefense graduate student Georgia Ray has provided us with a detailed summary of this Commission event. We’d also like to show off her blog, Eukaryote Writes, which just so happens to delve into bioweapons and how close we’ve gotten to actual use. Georgia notes “I’ve heard a lot about ‘nuclear close calls.’  Stanislav Petrov was, at one point, one human and one uncomfortable decision away from initiating an all-out nuclear exchange between the US and the USSR. Then that happened several dozen more times. As described in Part 1, there were quite a few large state biological weapons programs after WWII. Was a similar situation unfolding there, behind the scenes like the nuclear near-misses?” In Georgia’s in-depth review of the Cyberbio Convergence event, she notes that “Tom Dashchle described biosecurity as a cause area with ‘broad support but few champions’ and agreed with the importance of creating career paths and pipelines into the field. (Great news for optimistic current Biodefense program students like myself.) The panel also agreed on the importance of education starting earlier, through STEM education and basic numeracy skills.”

1918/1919 Pandemic Museum Exhibit
Check out the Mutter Museum for a permanent exhibit on the influenza pandemic that hit Philadelphia, PA. “On Sept. 28, 1918, in the waning days of World War I, over 200,000 people gathered along Broad Street in Philadelphia for a parade meant to raise funds for the war effort. Among the patriotic throngs cheering for troops and floats was an invisible threat, which would be more dangerous to soldiers and civilians than any foreign enemy: the influenza virus. Officials went ahead with the parade despite the discouragement of the city health department about the ever-spreading virus. Within 72 hours of the parade, all the hospital beds in Philadelphia were full of flu patients. Within six weeks, more than 12,000 people died — a death every five minutes — and 20,000 had died within six months.” Named “Spit Spreads Death”, the exhibit opens on October 17th and will include interactive maps, artifacts, and images. Personal stories and accounts from historians brings this exhibit to life and drives home the message.

The Story of Technology
GMU biodefense doctoral alum Dr. Daniel Gerstein has the latest book for you to add to the reading list – The Story of Technology.  “Technology–always a key driver of historical change–is transforming society as never before and at a far more rapid pace. This book takes the reader on a journey into what the author identifies as the central organizing construct for the future of civilization, the continued proliferation of technology. And he challenges us to consider how to think about technology to ensure that we humans, and not the products of our invention, remain in control of our destinies? In this informative and insightful examination, Dr. Daniel M. Gerstein–who brings vast operational, research, and academic experience to the subject–proposes a method for gaining a better understanding of how technology is likely to evolve in the future. He identifies the attributes that a future successful technology will seek to emulate and the pitfalls that a technology developer should try to avoid. The aim is to bring greater clarity to the impact of technology on individuals and society.” As General David Petraeus (former commander of the troop surge in Iraq, US Central Command, and Coalition Forces in Afghanistan, and former director of the CIA), noted “Gerstein brings a unique perspective to The Story of Technology, as both a national security expert and a technologist. He examines, in a compelling fashion, the inextricable link between humans and technological advancement—and specifically how the latter has granted America security, economic, and societal advantages. But he also cautions, rightly, that many of the foundations on which these advantages have been built are eroding, threatening our interests and perhaps even redefining what it means to be human. This book is a must-read for our national leaders, technology specialists, and general readers alike.”

Starting with the focus on food safety that we saw within the FDA Food Safety Modernization Act (FSMA), the FDA is launching a new tool to help ensure food safety and security occurs in the U.S. “The new Food Safety Dashboard launched today is part of FDA-TRACK, which is one tool the FDA uses to monitor certain FDA programs through key performance measures and projects, and regularly updates to ensure transparency to the public. While we expect that it will take several years to establish trends in the data, the initial data show that since 2016, the majority of companies inspected are in compliance with the new requirements of the preventive control rules. Additional FDA data also show that overall, industry has improved the time it takes to move from identifying a recall event to initiating a voluntary recall, from an average of four days in 2016 to approximately two days in 2019. In fact, comparing the FSMA data with our recall data shows the bigger picture, demonstrating the effectiveness of preventive measures as food recalls once again have reached a five-year low.”
Ebola Outbreak Update
As cases continue to be identified, albeit slowly (total is now 3,198),  much focus has been on community resistance as new research is being released. Researchers “explored community resistance using focus group discussions and assessed the prevalence of resistant views using standardized questionnaires. Despite being generally cooperative and appreciative of the EVD response (led by the government of DRC with support from the international community), focus group participants provided eyewitness accounts of aggressive resistance to control efforts, consistent with recent media reports. Mistrust of EVD response teams was fueled by perceived inadequacies of the response effort (“herd medicine”), suspicion of mercenary motives, and violation of cultural burial mores (“makeshift plastic morgue”). Survey questionnaires found that the majority of respondents had compliant attitudes with respect to EVD control. Nonetheless, 78/630 (12%) respondents believed that EVD was fabricated and did not exist in the area, 482/630 (72%) were dissatisfied with or mistrustful of the EVD response, and 60/630 (9%) sympathized with perpetrators of overt hostility. Furthermore, 102/630 (15%) expressed non-compliant intentions in the case of EVD illness or death in a family member, including hiding from the health authorities, touching the body, or refusing to welcome an official burial team.” GMU Biodefense doctoral alum Saskia Popescu notes that “This research shed light on many of the suspected social dynamics that challenge response efforts but also delved into detail of what is needed to refine education and community outreach to truly be effective.” The U.K. has issued Tanzania travel warnings over a probable Ebola death. “The U.K. advised travelers to Tanzania to be aware of a ‘probable’ Ebola-related death in the East African nation, its Foreign and Commonwealth Office said Tuesday in a statement on its website. About 75,000 British nationals visit Tanzania every year, it said.”
James F. McDonnell, a presidential appointee who over the last two years downsized the Department of Homeland Security’s efforts to prevent terrorism involving weapons of mass destruction, has agreed to resign. McDonnell’s resignation, department sources said, comes at the request of acting Homeland Security Secretary Kevin McAleenan and would become effective at noon on Thursday, according to an email McDonnell sent his staff at 12:57 p.m. EDT on Wednesday. McDonnell’s seven-sentence memo did not provide a reason for his resignation, saying only it was ‘time for a new leadership team to take things to the next level’.”
“Perhaps one of the increasingly more apparent challenges of battling antimicrobial resistance is that of surveillance. This presentation by Michael Y. Lin, MD, MPH, of Rush University Medical Center, discussed the Illinois XDRO Registry. Created in 2013, this data source for XDROs focuses on carbapenem-resistant Enterobacteriaceae (CRE), carbapenemase-producing Pseudomonas aeruginosa, and Candida auris. The registry essentially allows health care facilities to access data to identify if patients being admitted have a history of colonization or infection with the aforementioned organisms.  Data is submitted through hospitals and allows for alerts to be created, automatically, which are sent via email, page, or even a text to the hospital’s infection preventionist when the patient is admitted. Perhaps one of the increasingly more apparent challenges of battling antimicrobial resistance is that of surveillance. This presentation by Michael Y. Lin, MD, MPH, of Rush University Medical Center, discussed the Illinois XDRO Registry. Of those patients who were unknown to the facilities, 33% were not in contact precautions when the alert occurred, indicating that it is highly beneficial for reducing disease transmission.”

Stories You May Have Missed:

  • EEE Cases Continue in Michigan – “The threat from Eastern Equine Encephalitis is continuing to grow, especially in Michigan where state health officials now say 12 counties have confirmed having human or animal cases of EEE. The mosquito-borne virus usually infects only about seven people annually, but there have been 28 human cases reported so far this year across the country. Nine people have died.”

 

Pandora Report 9.27.2019

What a week it has been – from CW conspiracy theories to Tanzanian Ebola scares, the world of biodefense has been pretty busy.

Controversy Over Syrian CW Conspiracy Theory Claims
There’s been a lot of conversation regarding Syrian chemical weapons lately and not in the way you might anticipate. GMU Biodefense Graduate Program Director and Professor (and CW/BW expert) Dr. Gregory Koblentz is breaking down some of the conspiracy theories, debates, and why overwhelming evidence just can’t be ignored. “The journal Science and Global Security is embroiled in a controversy surrounding its acceptance of an article co-authored by Ted Postol, a former MIT professor and missile defense expert and member of the journal’s editorial board. For the last six years, Postol has promoted a variety of conspiracy theories that deny that the Syrian government is responsible for using chemical weapons against its own people despite overwhelming evidence to the contrary.”

Tanzania’s Ebola Problem and Outbreak Updates
This week saw a tense situation between the WHO and Tanzania, as “the World Health Organization took the unusual step on Saturday of issuing a statement detailing multiple suspected cases of Ebola in Tanzania and criticizing the government for withholding clinical samples for additional testing. The United Nations public-health agency said that it had received unofficial reports of at least one Tanzanian patient testing positive for Ebola, while at least three others were hospitalized with symptoms of the disease in different parts of the country.” In this rather unprecedented situation, the WHO was vocal in concern and frustration. The outbreak in the DRC continues to grow, as four more cases were reported on Wednesday. The total cases are now 3,175, with officials continuing to follow 445 suspected cases.

Vektor’s Explosion – The Big Uh-Oh?
Since last week’s news of an explosion at the State Research Centre of Virology in Russia, there’s been a lot of discussion regarding what really happened, but also what this means for smallpox stockpiles, biosecurity, and biosafety. “From a risk analysis perspective, an explosion at a BSL 4 facility for dangerous, contagious pathogens is a risk for global health. Despite the Russian government assertion that there is no risk to public health, it would be wise to assess the risk as objectively as possible, given the global community is a stakeholder if an epidemic arises from this accident. In the best-case scenario, there were no pathogens in the affected part of the building, no pathogens released, the situation has been contained and there is no risk to local or global public health. In the worst-case scenario, there were pathogens present at the time, which were aerosolised and propagated outside the building as a result of the explosion. The principle of pandemic and preparedness planning considers the worst-case scenario, rather than hoping for the best-case scenario. So, we need to consider what a worst-case scenario would look like and how best to be prepared and mitigate it.” Matt Field of the Bulletin of the Atomic Scientists also discussed what this means, noting that the “blast follows relatively closely on the heels of another explosion at a Russian facility conducting high-tech and risky research. In August, an accident at a missile test site killed five nuclear scientists. US officials believe researchers at the site were working on a nuclear-powered cruise missile.”

Meet the DoD’s New Assistant Director for Biotechnology
“Dr. Titus is the new Assistant Director for Biotechnology in the Office of the Under Secretary of Defense for Research & Engineering. The Department of Defense (DoD) provides the military forces needed to deter war and ensure the United States’ security. The US military is currently undergoing a modernization initiative. Dr. Titus leads biotechnology modernization, one of several new priorities within the DoD’s research program. His job: develop a ten-year roadmap to keep the nation’s defenses at the leading edge of biotechnology and specifically synthetic biology: the process of making biology easier to engineer.” When asked what keeps him up at night, Dr. Titus noted “Being left behind. And the reason is that when you start to slow down, you lose grasp on what is cutting edge and what is coming around the corner,” Dr. Alexander Titus replies. “It is the Department’s responsibility to understand what the threats are to the United States,”. From synthetic biology to modernizing armor to become self-healing, Dr. Titus’s work is to strengthen military capability through biotechnology while building a more symbiotic relationship with biology.

Via STAT News

Lower Customized DNA Kit Prices Meet Higher Risks
There has always been concern that with customized DNA available, the risk for use by nefarious actors would also grow. As efforts become cheaper, there’s been increasing focus on how we can prevent such technology from being misused. “What makes DNA so powerful, after all, also makes it potentially dangerous. Someone could use it to change a harmless bacteria into one that makes a deadly toxin. And scientists have already shown that it’s possible to use bits of DNA to construct viruses like polio and Ebola. James Diggans, Twist’s director of biosecurity, says they check out every potential customer. They also analyze each requested DNA sequence, to see if there’s anything worrisome in there, like a gene specific to some nasty germ.”

FDA Approves First Live, Non-replicating Vaccine Against Smallpox/Monkeypox
Jynneos is now officially approved by the FDA against monkeypox and smallpox. The vaccine was just approved “for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. This is the only currently FDA-approved vaccine for the prevention of monkeypox disease. ‘Following the global Smallpox Eradication Program, the World Health Organization certified the eradication of naturally occurring smallpox disease in 1980. Routine vaccination of the American public was stopped in 1972 after the disease was eradicated in the U.S. and, as a result, a large proportion of the U.S., as well as the global population has no immunity,’ said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. ‘Therefore, although naturally occurring smallpox disease is no longer a global threat, the intentional release of this highly contagious virus could have a devastating effect. Today’s approval reflects the U.S. government’s commitment to preparedness through support for the development of safe and effective vaccines, therapeutics, and other medical countermeasures’.” In efforts to enhance health security, HHS is also sponsoring the development of therapeutics for smallpox infections. “Under the agreement announced today, the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), will work with BioFactura, Inc., of Frederick, Maryland, providing expertise and $9.5 million over two years to develop a monoclonal antibody treatment for smallpox. BARDA has options to support additional work, providing up to a total of $67.4 million over five years. BioFactura is developing a treatment that uses multiple monoclonal antibodies, a combination known as a monoclonal antibody cocktail. Monoclonal antibodies bind specific proteins on the virus to neutralize it, decreasing the amount of the virus in the body that the immune system must fight. Testing in non-clinical studies showed that the antibody cocktail neutralizes the variola virus, which causes smallpox and related viruses.”

Bipartisan Commission on Biodefense – Defense of Agriculture Meeting
“On November 5, 2019, we will convene a meeting of the Commission, Too Great a Thing to Leave Undone: Defense of Agriculture, to inform our continuing assessment of the biological threat, specific vulnerabilities, and overwhelming consequences to agricultural producers. Topics to be discussed at this meeting include: the catastrophic risks to all components of agriculture; land grant university contributions to national security; public-private partnerships for agrodefense, and challenges to agricultural surveillance, detection, response, and recovery across all levels of government and throughout the private sector.”

Nuclear Security Concerns
Sure, a lot of us have binge-watched Chernobyl, but the truth is that many American nuclear security experts continue to have some very real concerns. “For nearly two decades, the nation’s nuclear power plants have been required by federal law to prepare for such a nightmare: At every commercial nuclear plant, every three years, security guards take on a simulated attack by hired commandos in so-called ‘force-on-force’ drills. And every year, at least one U.S. nuclear plant flunks the simulation, the ‘attackers’ damaging a reactor core and potentially triggering a fake Chernobyl – a failure rate of 5 percent. In spite of that track record, public documents and testimony show that the Nuclear Regulatory Commission, the federal agency responsible for ensuring the safety and security of the nation’s fleet of commercial nuclear reactors, is now steadily rolling back the standards meant to prevent the doomsday scenario the drills are designed to simulate. Under pressure from a cash-strapped nuclear energy industry increasingly eager to slash costs, the commission in a little-noticed vote in October 2018 halved the number of force-on-force exercises conducted at each plant every cycle. Four months later, it announced it would overhaul how the exercises are evaluated to ensure that no plant would ever receive more than the mildest rebuke from regulators – even when the commandos set off a simulated nuclear disaster that, if real, would render vast swaths of the U.S. uninhabitable.”

Stories You May Have Missed:

  • Canine Detection of C-diff Spores: “Outside of rooms and spaces that have been clearly identified as contaminated with C diff spores (i.e. a patient with an active infection has stayed in the space), it can be difficult to know where to properly disinfect with spore-killing measures. One particular approach though has gotten a lot of attention – C diff canine scent detection. That’s right, specially trained dogs are being used to sniff out this bug to help guide environmental cleaning efforts.  Vancouver Coastal Health is one place that’s leading the pack (literally and figuratively) in the use of C diffcanine scent detection. A team recognized that 60% of cases are related to health care transmission and worked to develop a program to help train dogs to detect C diff with 97% accuracy.”

 

Pandora Report: 9.6.2019

Happy Friday! We hope you had a lovely week as the summer winds down. If you’re considering reading the latest Richard Preston book, you might want to check out this review.

Journal of Biosecurity, Biosafety and Biodefense Law 
Volume 10 is now available, which “offers both a legal and scientific perspective on current issues concerning bioterrorism, public health and safety, and national security. Edited by an international board of leading scholars from all the continents, our journal is aware that bioterrorism related issues are global problems. Our goal is to develop a unique international community of legal scholars, scientists and policy experts who will address current issues in these fields.” Within this latest volume, you can find articles on vaccine exemptions, the looming threat of agroterrorism, the history of tuberculosis quarantine, and much more.

The Oversecuritization of Global Health: Changing the Terms of Debate
“Linking health and security has become a mainstream approach to health policy issues over the past two decades. So much so that the discourse of global health security has become close to synonymous with global health, their meanings being considered almost interchangeable. While the debates surrounding the health–security nexus vary in levels of analysis from the global to the national to the individual, this article argues that the consideration of health as a security issue, and the ensuing path dependencies, have shifted in three ways. First, the concept has been broadened to the extent that a multitude of health issues (and others) are constructed as threats to health security. Second, securitizing health has moved beyond a rhetorical device to include the direct involvement of the security sector. Third, the performance of health security has become a security threat in itself. These considerations, the article argues, alter the remit of the global health security narrative; the global health community needs to recognize this shift and adapt its use of security-focused policies accordingly.”

The Soldiers Who Took On Yellow Fever
Battling Aedes aegypti to help combat Yellow Fever isn’t for the faint of heart and here’s insight into how it went down. “The Yellow Fever Board, led by then-Major Walter Reed and Jesse Lazear, had convened at the Army’s Columbia Barracks in Cuba, at the height of a deadly yellow fever epidemic ravaging Cuba in 1900. Today, we know that yellow fever spreads when Aedes aegypti mosquitoes bite infected people, then carry the virus to the next person they bite. But in 1900, American doctors weren’t sure if the virus spread through infected blood, or through traces of infected material on bedding. Volunteer soldiers subjected themselves to living in yellow fever survivor filth, and later to mosquito bite tests, to advance understanding of disease transmission.”

Lyme Disease – It’s Not A Bioweapon… 
In case you missed the several other times we mentioned how Lyme disease isn’t an escaped bioweapon….here’s another breakdown. “One of the most important characteristics of a biowarfare agent is its ability to quickly disable target soldiers. The bacteria that cause Lyme disease are not in this category. Many of the agents that biowarfare research has focused on are transmitted by ticks, mosquitoes, or other arthropods: plague, tularemia, Q fever, Crimean Congo hemorrhagic fever, Eastern equine encephalitis or Russian spring summer encephalitis. In all of them, the early disease is very debilitating, and the fatality rate can be great; 30 percent of Eastern equine encephalitis cases die. Epidemic typhus killed 3 million people during World War I. Lyme disease does make some people very sick but many have just a flu-like illness that their immune system fends off. Untreated cases may subsequently develop arthritis or neurological issues. The disease is rarely lethal. Lyme has a weeklong incubation period – too slow for an effective bioweapon. And, even though European physicians had described cases of Lyme disease in the first half of the 20th century, the cause had not been identified. There was no way the military could have manipulated it because they did not know what ‘it’ was.”

Why We Need More Open-Source Epidemiological Tools 
“A newer tool, though, is changing the game in outbreak response and modeling. The Spatiotemporal Epidemiologic Modeler (STEM) is an open-source software that is available to the global health community. This is not just a rigid instrument against disease, in that it is not pre-set to a specific disease or environment and has the flexibility for hundreds of variations. ‘STEM has been used to study variations in transmission of seasonal influenza in Israel by strains; evaluate social distancing measures taken to curb the H1N1 epidemic in Mexico City; study measles outbreaks in part of London and inform local policy on immunization; and gain insights into H7N9 avian influenza transmission in China. A multi-strain dengue fever model explored the roles of the mosquito vector, cross-strain immunity, and antibody response in the frequency of dengue outbreaks,’ the authors of a briefing in Health Security wrote.
The latest version was just released this year and allows users to really refine it based on their needs. From Ebola in West Africa to Salmonella in Germany, it has been used by agencies and universities alike. In fact, one of the authors, Nereyda Sevilla, PhD, used it for her doctoral dissertation work to model SARS, H1N1, and pneumonic plague in air travel in order to assess its role as a vector in the transmission of infectious diseases. What makes STEM so helpful to users is not only that it’s open access, but also its wide application and historical usage in tracking multi-strain vector-borne diseases, human behavioral responses, earth science data, pathogens from farm to fork, and so much more.”

Ebola Outbreak Updates
This week, cases of Ebola virus disease continued to rise in the DRC, as 6 were reported over 4 days, bringing to the outbreak to 3,043 cases and 2,035 deaths. The epidemiological investigation into the 9-year-old girl who died from Ebola in Uganda last week is also pointing to a potential nosocomial source for her infection. “The cases were confirmed during a weekend of unrest throughout the outbreak region, including Kalunguta, where a motorcycle was burned and several people clashed with local Ebola response agents who were attempting to perform a safe and dignified burial for a patient. According to translated media reports, the conflict began when family members protested the declaration of the deceased as an Ebola patient. In the latest update from the World Health Organization’s (WHO’s) African regional office, the WHO says the new ‘hot spot’ status of Kalunguta is of highly worrisome. ‘A review of key performance indicators at week 34 (19-25 August 2019) shows, in comparison with the previous week, an increase in the number of new confirmed cases, a decrease in the proportion of deaths on notification, persistence of the low proportion of new confirmed cases listed as contacts and an extension of affected health areas,’ the WHO said. ‘All these, along with the addition of Kalunguta as a hot spot area, are of grave concern’.”

Restricting the Use of Riot-Control Chemicals 
Mounting discussions to restrict the use of riot-control chemicals have come in the face of use in Hong Kong and the US-Mexico border. “Police forces use these riot-control chemicals to clear crowds or to stop fighting. In theory, exposure should be minimal — a group should disperse within minutes to avoid the gas. The line between civilian and military applications of these chemical agents is a fine one. Rules governing their use are confused. Reference books and training materials continue to cite toxicology studies from the 1950s. And those were done on animals and soldiers, not the public. The chemicals involved are mainly CS (2-chlorobenzalmalononitrile, the primary component of tear gas) and OC (oleoresin capsicum, a chilli-pepper extract used in pepper spray). Tear gases were developed to harass the enemy or to clear bunkers and tunnels in conflicts such as the Vietnam War, as alternatives to deadly force. Pepper sprays came into use in the 1980s for police and self-defence use after being developed as an animal repellent in the 1960s.”

Identifying and Responding to Newly Resistant Infections
Infection preventionist and GMU biodefense doctoral alum Saskia Popescu discusses the frontlines of antimicrobial resistance surveillance and response. “In the world of growing antimicrobial resistance, the identification of patients with highly resistant (or newly resistant) infections is critical. Because this is an emerging challenge, national and international surveillance efforts are still being strengthened to tackle all the avenues that contribute to antimicrobial resistance. The frontline identification of these newly resistant infections is critical though and surveillance is not only the first step in identifying and understanding the problem, but it also allows us to properly isolate the patient to avoid further transmission. Bacteria like Klebsiella pneumoniae are increasingly developing resistance to antimicrobials and can easily be spread through health care facilities. Klebsiella bacteria are also showing a relatively new resistance to the carbapenem class of antibiotics. Typically, these bacteria cause infections like pneumonia, bloodstream infections, wound or surgical site infections, and even urinary tract. A recent publication in the US Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report (MMWR) described experiences surrounding the identification of a Klebsiella pneumoniae isolate that had 3 carbapenem-resistant genes (CR-Kp) and was related to urinary procedures.”

Surgical Masks vs. N95s
In the battle against influenza, there can only be one..”In outpatient settings, surgical masks and more expensive respirator masks appear to be equally effective for protecting health workers against flu and other respiratory viruses, according to a new study based on data over four flu seasons. Earlier studies comparing the two forms of respiratory protection have shown mixed results. Uncertainty over which is better has been a sticking point in forming recommendations on how best to protect healthcare workers, especially during the 2009 H1N1 pandemic. And the new findings come in the wake of 2018 research that showed that flu likely also spreads by small aerosol particles, not just by respiratory droplets. Tighter-fitting N95 masks are designed to filter at least 95% of airborne particles, but some healthcare workers find them less comfortable than surgical masks, leading to problems with adherence. During the 2009 H1N1 flu pandemic, some hospitals and clinics had problems restocking their N95 supplies.”

GMU Research Team Sequence Komodo Dragon Genome
“George Mason University researchers Monique van Hoek and Barney Bishop and their collaborators have released their findings on sequencing the Komodo dragon genome, revealing multiple clusters of antimicrobial peptide genes that could prove instrumental in the fight against multi-drug resistant bacteria. Their work, which was published in the latest issue of BMC Genomics, identified key clusters of Komodo dragon antimicrobial peptide genes, which are protein-like molecules that contribute to the front line defense of its immune system. Komodo dragons are resilient reptiles with robust immune systems that regularly dine on dead and decaying flesh and whose saliva is known to be rich in bacteria.”

Stories You May Have Missed:

  • Brooklyn Measles Outbreak Over – “Today the Centers for Disease Control and Prevention (CDC) confirmed 19 new measles infections, raising the 2019 total to 1,234 cases in 31 states. One additional state has been affected since the CDC’s last update, but the number of active outbreaks has been reduced to four, down from six noted last week. As of Aug 29, 125 of measles case-patients had been hospitalized, and 65 reported having complications, including pneumonia and encephalitis, the CDC said. More than 75% of measles cases recorded in 2019 have come from two outbreaks among New York State’s Orthodox Jewish communities—one in Williamsburg, Brooklyn, and one in Rockland County.”

Pandora Report: 6.28.2019

Summer Workshop – Early Registration Discount Ends Soon
Just a few more days to get your early registration discount and we’ve only got a few spots left – make sure to grab yours! We’re excited to have top professionals and researchers in the health security field speak to the biological threats we’re facing- from securing the bioeconomy to vaccine development and pandemic preparedness, you’ll want to be there for the 3.5 days of all things pandemics, bioterrorism, and global health security.

Re-thinking Biological Arms Control for the 21st Century
Dr. Filippa Lentzos discusses the challenges of biological arms control in the face of synthetic biology and technological advances. “Innovations in biotechnology are expanding the toolbox to modify genes and organisms at a stagger- ing pace, making it easier to produce increasingly dangerous pathogens. Disease-causing organisms can now be modified to increase their virulence, expand their host range, increase their transmissibility, or enhance their resistance to therapeutic interventions. Scientific advances are also making it theoretically possible to create entirely novel biological weapons, by synthetically creating known or extinct pathogens or entirely new pathogens. Scientists could potentially enlarge the target of bioweapons from the immune system to the nervous system, genome, or microbiome, or they could weaponize ‘gene drives’ that would rapidly and cheaply spread harmful genes through animal and plant populations.” Lentos notes that “The political backdrop to these technical advances in biotechnologies and other emerging technologies is also important. There is increased worldwide militarization, with global military spending at an all-time high since the fall of the Berlin Wall. Unrestrained military procurement and modernization is creating distrust and ex- acerbating tensions. In the biological field, the proliferation of increasingly sophisticated biodefense capacities, within and among states, can lead to nations doubting one another’s intentions.”

GAO – Biodefense: The Nation Faces Long-Standing Challenges Related to Defending Against Biological Threats
The GAO testified before a House committee on their efforts to identify and strengthen U.S. biodefense and here are their overall findings in a report. Despite President Trump signing off on the Pandemic and All-Hazards Preparedness and Advancing Innovations Act (PAHPA) on Monday, there is still a lot of work to be done. “Catastrophic biological events have the potential to cause loss of life, and sustained damage to the economy, societal stability, and global security. The biodefense enterprise is the whole combination of systems at every level of government and the private sector that contribute to protecting the nation and its citizens from potentially catastrophic effects of a biological event. Since 2009, GAO has identified cross-cutting issues in federal leadership, coordination, and collaboration that arise from working across the complex interagency, intergovernmental, and intersectoral biodefense enterprise. In 2011, GAO reported that there was no broad, integrated national strategy that encompassed all stakeholders with biodefense responsibilities and called for the development of a national biodefense strategy. In September 2018, the White House released a National Biodefense Strategy. This statement discusses GAO reports issued from December 2009 through March 2019 on various biological threats and biodefense efforts, and selected updates to BioWatch recommendations made in 2015. To conduct prior work, GAO reviewed biodefense reports, relevant presidential directives, laws, regulations, policies, strategic plans; surveyed states; and interviewed federal, state, and industry officials, among others.” GAO identified several challenges in the ability for the U.S. to defend against biological threats: “Assessing enterprise-wide threats. In October 2017, GAO found there was no existing mechanism across the federal government that could leverage threat awareness information to direct resources and set budgetary priorities across all agencies for biodefense. GAO said at the time that the pending biodefense strategy may address this. Situational awareness and data integration. GAO reported in 2009 and 2015 that the Department of Homeland Security’s (DHS) National Biosurveillance Integration Center (NBIC)—created to integrate data across the federal government to enhance detection and situational awareness of biological events—has suffered from longstanding challenges related to its clarity of purpose and collaboration with other agencies. DHS implemented GAO’s 2009 recommendation to develop a strategy, but in 2015 GAO found NBIC continued to face challenges, such as limited partner participation in the center’s activities. Biodetection technologies. DHS has faced challenges in clearly justifying the need for and establishing the capabilities of the BioWatch program—a system designed to detect an aerosolized biological terrorist attack. In October 2015, GAO recommended that DHS not pursue upgrades until it takes steps to establish BioWatch’s technical capabilites. While DHS agreed and described a series of tests to establish capabilities, it continued to pursue upgrades. Biological laboratory safety and security. Since 2008, GAO has identified challenges and areas for improvement related to the safety, security, and oversight of high-containment laboratories, which, among other things, conduct research on hazardous pathogens—such as the Ebola virus. GAO recommended that agencies take actions to avoid safety and security lapses at laboratories, such as better assessing risks, coordinating inspections, and reporting inspection results. Many recommendations have been addressed, but others remain open, such as finalizing guidance on documenting the shipment of dangerous biological material.”

ABSA 1st International Biosecurity Symposium Call for Papers
“You are now able to submit papers for ABSA’s 1st International Biosecurity Symposium. The symposium will take place May 12-15, 2020 in Minneapolis, Minnesota. We anticipate having attendees from all over the world and approximately 20 commercial exhibits. The professional development courses will take place Tuesday, May 12, 2020. The symposium presentations (platform/poster) will take place Wednesday, May 13 to Friday, May 15, 2020. The Call for Platform/Posters Abstract submission deadline is July 31, 2019 at 5pm Central.”

Blue Ribbon Panel – U.S. Is Not Prepared for Biological Incidents – Testimony
June 26th- “Dr. Asha George, Executive Director of the Blue Ribbon Study Panel on Biodefense, served as an expert witness this afternoon before the House Oversight and Reform Subcommittee on National Security. Chaired by Rep. Stephen Lynch (MA), the Subcommittee is evaluating the readiness of the U.S. government and healthcare system, including hospital and emergency professionals, to respond to naturally occurring pandemics and biological attacks that could be perpetrated by state and non-state actors. The Subcommittee also is investigating the growing threat of antimicrobial-resistance, as well as the implications of this challenge for U.S. national security. ‘Our Panel has assessed and continues to assess the state of our country’s biodefense. We scrutinize the status of prevention, deterrence, preparedness, detection, response, attribution, recovery, and mitigation – the spectrum of activities necessary for biodefense,’ said Dr. George. ‘As expected, we found both strengths and weaknesses, including serious gaps that four years after the release of our Panel’s Blueprint for Biodefense in 2015 continue to make the nation vulnerable. In short, the nation is not prepared for biological outbreaks, bioterrorist attacks, biological warfare, or accidental releases with catastrophic consequences’.” This is especially relevant as many are wondering what Congress is doing to respond to health security threats.

Ebola Outbreak – Updates
As of Wednesday, the outbreak has reached 2,277 cases and security threats are increasingly making response efforts challenging. “In its weekly situation report on the outbreak, the WHO said Ebola activity continues with steady and sustained intensity, with security incidents returning to Beni—one of the outbreak’s former major hot spots—and armed group movements in Musienene and Manguredjipa impeding access to a health area next to Mabalako’s hardest-hit area. Another concern it aired is a tense security situation in neighboring Ituri province cities Bunia and Komanda in the wake of attacks in early June. Over the past few weeks, indicators show hints of easing transmission intensity in the two biggest recent epicenters, Katwa and Butembo. However, the optimism is offset by new cases in previously affected areas, including Komanda, Lubero, and Rwampara. For example, over the past week, Komanda reported its first case after going 11 days without one.”

A Dose of Inner Strength to Survive and Recover from Potentially Lethal Health Threats
“Breakthroughs in the science of programmable gene expression inspired DARPA to establish the PReemptive Expression of Protective Alleles and Response Elements (PREPARE) program with the goal of delivering powerful new defenses against public health and national security threats. DARPA has now selected five teams to develop a range of new medical interventions that temporarily and reversibly modulate the expression of protective genes to guard against acute threats from influenza and ionizing radiation, which could be encountered naturally, occupationally, or through a national security event. The program builds from the understanding that the human body has innate defenses against many types of health threats, but that the body does not always activate these defenses quickly or robustly enough to block the worst damage. To augment existing physiological responses, PREPARE technologies would provide a programmable capability to up- or down-regulate gene expression on demand, providing timely, scalable defenses that are proportional to anticipated threats. Service members and first responders could administer these interventions prior to threat exposure or therapeutically after exposure to mitigate the risk of harm or death.”

Global Community Bio Summit 3.0
From October 11-13, you can attend this community biotechnology initiative at MIT Media Lab. “The Community Biotechnology Initiative at the MIT Media Lab is organizing the third annual Global Summit on Community Biotechnology this October 11 to 13, 2019! Our goal is to provide a space for the global community of DIY biologists / community biologists / biohackers / biomakers and members of independent and community laboratories to convene, plan, build fellowship, and continue the evolution of our movement. You can learn more about last year’s Summit, including our program, here. While all are welcome, space is limited, so we are prioritizing active practitioners in the community with an emphasis on diversity across geographic, cultural, ethnic, gender, and creative backgrounds. We will add accepted participants to the directory on a rolling basis with the goal of accepting everyone interested in joining.”

Stories You May Have Missed:

  • Tackling Dirty Sinks – Did you ever think your hospital sink could be a disease reservoir? “Earlier this year, there were studies that identified sink proximity to toilets as a risk factor for contamination. Bugs like Klebsiella pneumoniae carbapenemase-producing organisms tend to be prolific in moist environments and are often pervasive in intensive care unit sinks and drains. Researchers found that sinks near toilets were 4-times more likely to host the organisms than those further from toilets. More and more, infection prevention is having to look at hospital faucets and sinks for their role in hosting microbial growth. This was also a topic of interest at last week’s annual conference of the Association for Professionals in Infection Control and Epidemiology (APIC 2019). Investigators with the University of Michigan Health System discussed how they worked to identify vulnerabilities and potential sink designs that might contribute to bioburden and biofilm in hospital faucets. Assessing 8 different designs across 4 intensive care units, the research team ultimately found that those sinks with a more shallow depth tended to allow higher rates of contamination (ie, splash of dirty water) onto equipment, surfaces, and patient care areas. In some instances, the splash of contaminated water could be found up to 4 feet from the sink.”

 

Pandora Report: 6.6.2019

Happy Thursday! That’s right – you’re getting your weekly dose of biodefense news a tad early, but don’t worry, we’ll be back to our normal schedule next week! Have you registered for the Summer Workshop on Pandemics, Bioterrorism, and Global Health Security? From anthrax to Zika, we’ll be covering all the topics, debates, and threats related to health security.

GMU Welcomes New Faculty Member – Dr. Ashley Grant
We’re excited to announce that Dr. Ashley Grant, a lead biotechnologist at the MITRE Corporation, is joining the Biodefense Program as an Adjunct Professor to teach BIOD 620: Global Health Security Policy. Dr. Grant was previously the Senior Biological Scientist at the Government Accountability Office where she led government-wide technical performance audits focused on biosafety and biosecurity issues. Dr. Grant was an American Association for the Advancement of Science (AAAS) Science and Technology Fellow in the Chemical and Biological Defense Program Office in the Department of Defense and also worked at the National Academies of Science on the Committee on International Security and Arms Control. Her work focused on international security, nonproliferation, and medical countermeasures against chemical and biological threats. She completed the Field Epidemiology Course at the Naval Medical Research Center (NMRC) in Lima, Peru and was a Visiting Graduate Researcher at the Instituto Nacional de Enfermedades Virales Humanas J. Maitegui (INEVH) in Pergamino, Argentina. Dr. Grant received her PhD in experimental pathology and a MPH in epidemiology from the University of Texas Medical Branch at Galveston. Her graduate work focused on investigating pathogenesis and potential countermeasures for viral hemorrhagic fevers under biological safety level (BSL)-4 conditions. In addition, she received a MA in National Security Studies from the Naval War College and a BS in Chemistry and a BS in Business Economics and Management from the California Institute of Technology.

Congress Passes the Pandemic and All-Hazards Preparedness and Advancing Innovation Act
On Tuesday, June 4th, the House “passed the Pandemic and All-Hazards Preparedness and Advancing Innovation Act. The bill reauthorizes existing statute governing public health efforts at the Department of Health and Human Services. Additions made by the bill – some of which were recommended by the Blue Ribbon Study Panel on Biodefense – address biodetection, hospital preparedness, medical countermeasures and response. Many of these programs will enable HHS to better defend the nation against biological threats. Both chambers of Congress have passed the bill, and it will now go to President Trump for signature. ‘Naturally occurring diseases and biological weapons continue to endanger our nation,’ said Governor Tom Ridge, Panel Co-Chair. ‘The Panel is pleased to see that Congress addressed 15 of our recommendations in this legislation, which will help the nation better prepare for, detect, respond to, and recover from large-scale biological events, bioterrorism or other biological events’.”

National Biodefense Science Board Public Meeting
“The June 10-11, 2019 meeting of the National Biodefense Science Board will focus on early results and progress reports from four new programs that were designed to strengthen disaster health preparedness, response and recovery: the Regional Disaster Health Response System; BARDA DRIVe; ASPR’s new Incident Management Team; One Health; and the National Biodefense Strategy. As part of the evolution of the National Disaster Medical System, NBSB will discuss disaster veterinary medicine and National Veterinary Response Teams. The board will also address issues facing the medical community, including disaster medicine training for community physicians and advance practice physicians and learn about ways to develop and operationalize core competencies for disaster medicine.”

 Exploring Lessons Learned from a Century of Outbreaks
Check out the latest from the proceedings of a 2019 NAS workshop on outbreak readiness. “In November 2018, an ad hoc planning committee at the National Academies of Sciences, Engineering, and Medicine planned two sister workshops held in Washington, DC, to examine the lessons from influenza pandemics and other major outbreaks, understand the extent to which the lessons have been learned, and discuss how they could be applied further to ensure that countries are sufficiently ready for future pandemics. This publication summarizes the presentations and discussions from both workshops.” Within this document, you can access sections on global preparedness progress for the next pandemic influenza, building local and national capacities for outbreak preparedness, pandemic vaccine considerations, etc. “The participants in this workshop examined the lessons from major outbreaks and explored the extent to which they have both been learned and applied in different settings. The workshop also focused on key gaps in pandemic preparedness and explored immediate and short-term actions that exhibited potential for the greatest impact on global health security by 2030. Workshop speakers and discussants contributed perspectives from government, academic, private, and nonprofit sectors. This workshop opened with a keynote address and a plenary presentation, followed by three sessions of presentations and discussions. Additionally, panelists, forum members, and attendees were given the opportunity to assemble into small groups and asked to consider potential priority actions and strategies for systematizing and integrating outbreak and pandemic preparedness so that it is a routine activity from the local to global levels.”

Inside Britain’s Top Secret Research Laboratory 
Have you ever wanted to tour Britain’s top secret laboratory? If Porton Down has been on your wish list, here’s your chance to get a virtual tour. “The BBC was given access inside Porton Down to see what the highly secretive facility was like and, for the first time ever, entered a cleansed version of a level four laboratory. This level is where the Defence Science and Technology Laboratory team analyse some of the world’s deadliest viruses – Ebola and Marburg.”

 DRC Ebola Outbreak Updates 
The outbreak has officially reached 2,000 cases and aid groups in “the region called for pushing the reset button on the response. In its daily update yesterday, the DRC said the outbreak passed the 2,000-case bar on Jun 2. Officials said that, although the landmark is concerning, the health ministry sees some positive signs, including a slight improvement in the security situation, though the situation remains volatile and unpredictable. The ministry added that most incidents related to community resistance have been resolved by community leaders, sensitizers, and psychosocial experts.” For many, the question is still – who is attacking Ebola responders and why? “The first is that local political figures are fomenting and even organizing the attacks as a way of undermining their rivals, presumably officials of the central government or local leaders aligned with them. Many analysts hold that it was actually the national government that set the stage for the use of the Ebola crisis as a political tool, and Gressly largely echoed that account. Last December, he noted, just days before presidential elections, national electoral officials announced that voting would be suspended in the two largest cities in the outbreak zone, Beni and Butembo.” “At least one type of attack appears very much linked: Many of the incidents seem to be outbursts by members of the community who have heard the rumors and believe them. An Ebola team will arrive in a neighborhood to bury a suspected Ebola patient or vaccinate their relatives, and people will throw rocks and chase the team out. Similarly, doctors and nurses at regular health facilities have been threatened by mobs, who are angry that the health workers refer Ebola patients to treatment centers. In one case, a nurse was killed. But there has also been an increase in seemingly well-coordinated assaults by well-armed assailants. More than half-a-dozen times, gunmen have shot up Ebola treatment centers and health facilities where Ebola teams are based, including on April 19, when a group of armed men burst into a hospital where an Ebola team was meeting and killed an epidemiologist with the World Health Organization.”

African Swine Fever and China’s Pork Industry
A highly virulent virus meets a $128 billion dollar industry and we’re not sure which will win. “The virus that causes the hemorrhagic disease is highly virulent and tenacious, and spreads in multiple ways. There’s no safe and effective vaccine to prevent infection, nor anything to treat it. The widespread presence in China means it’s now being amplified across a country with 440 million pigs—half the planet’s total—with vast trading networks, permeable land borders and farms with little or no ability to stop animal diseases.” Despite 50 years of efforts, there has been no vaccine for this devastating disease and “even if China is able to stop the virus transmitting from pig to pig, two other disease vectors may frustrate eradication efforts: wild boars and Ornithodoros ticks. These are the natural hosts of African swine fever virus and are widely distributed in China, though it’s not yet known what role they are playing in spreading the disease there. Zhejiang province, south of Shanghai, has about 150,000 wild boars.”

Stories You May Have Missed:

  • U.S. Measles Cases Top 1,000 – “Federal officials yesterday said US measles cases have reached 1,001, the first time since 1992 that cases have been in quadruple figures, while experts continued to urge vaccination and underscored the safety of the vaccine. Health and Human Services (HHS) Secretary Alex Azar said in an HHS news release, ‘We cannot say this enough: Vaccines are a safe and highly effective public health tool that can prevent this disease and end the current outbreak’.”
  • Nipah Virus in Indian Man – “The Indian government today confirmed that a 23-year-old man from Kerala has a Nipah virus infection, and another 86 case contacts are being monitored for the deadly disease, according to the Deccan Chronicle. Officials said the patient, a college student, is hospitalized and in stable condition. They also said two of the case contacts have fevers, and two nurses who took care of the 23-year-old were also experiencing fevers and sore throats.”
  • GM Fungus Kills 99% of Malaria Mosquitoes – “Trials, which took place in Burkina Faso, showed mosquito populations collapsed by 99% within 45 days. The researchers say their aim is not to make the insects extinct but to help stop the spread of malaria. The disease, which is spread when female mosquitoes drink blood, kills more than 400,000 people per year. Worldwide, there are about 219 million cases of malaria each year. Conducting the study, researchers at the University of Maryland in the US – and the IRSS research institute in Burkina Faso – first identified a fungus called Metarhizium pingshaense, which naturally infects the Anopheles mosquitoes that spread malaria. The next stage was to enhance the fungus. ‘They’re very malleable, you can genetically engineer them very easily,’ Prof Raymond St Leger, from the University of Maryland, told BBC News.”

 

Pandora Report 11.16.2018

We’re back from the 5th Ministerial Meeting of the Global Health Security Agenda (GHSA)! We’ll be reporting out on this event in the coming weeks, so keep an eye out for all things GHSA. Influenza season is ramping up and you’ll want to check out the latest article on looking beyond the decade of vaccines.

Preventing Pandemics and Bioterrorism: Past, Present, and Future
We’re just weeks away from this exciting event – are you registered? Preventing Pandemics and Bioterrorism: Past, Present, and Future is a special event in celebration of the 15th anniversary of the George Mason University Biodefense Program at the Schar School of Policy and Government. We invite you to attend this exciting opportunity to hear from Dr. Kadlec of ASPR about lessons learned for pandemic preparedness since the 1918-1919 influenza pandemic, plans for implementing the new National Biodefense Strategy, and the importance of education for the future of biodefense. Following his speech and Q&A session, you are invited to an informal reception for academic and professional members of the biodefense community to socialize and network. Make sure to RSVP soon as seats are limited for this December 4th event.

Russian Disinformation & the Georgian “Lab of Death”
A recent BBC investigation has found some disturbing information regarding Russian media making false claims about a U.S.-funded lab in Georgia. “The Russian Foreign Ministry, Defence Ministry and pro-Kremlin media claimed recently that untested drugs were given to Georgian citizens at the lab, resulting in a large number of deaths. The US has accused Russia of disinformation in order to distract attention away from incidents such as the Salisbury poisonings.” This episode is part of a series the BBC is providing on disinformation and fake news.

Ebola Outbreak Updates
The Ebola virus disease outbreak in the DRC continues to grow. 15 cases were reported on Monday as well as another violent attack in Beni. “WHO Director-General Tedros Adhanom Ghebreyesus, PhD, said on Twitter that he had been briefed on a violent attack that occurred in Beni on the night of Nov 10. ‘All WHO staff safe, but my heart goes out to families who have lost loved ones in this appalling and unacceptable attack, which we condemn in the strongest terms,’ he wrote. According to a local media report translated and posted by H5N1 Blog, which focuses on infectious disease news, at least five civilians were killed and several children kidnapped in an attack by rebels with the Allied Democratic Forces (ADF) in Beni’s Mayimoya district. The report said two other people were killed in two other attacks the same day in Beni’s Runwenzori neighborhood, one linked to ADF rebels and the other by suspected Mai Mai militia members.” The latest situation report lists 333 cases and 209 deaths, with 31 new confirmed cases reported during the reporting period (Nov 5-11). Early this morning, the DRC announced three more cases and 1 death. Health officials are also reportedly planning to launch a clinical trial of three antibody treatments and an antiviral drug, within the area. These drugs are currently in utilization in the Ebola treatment centers within the area but only under compassionate use. The UK is contributing funds to help Uganda step up prevention and preparedness efforts as well. “On a recent visit to The Medical Research Council/Uganda Virus Research Institute (URVI) and the London School of Hygiene and Tropical Medicine Research Unit in Entebbe, UK Minister for Africa Harriett Baldwin announced that the UK will support Uganda’s National Task Force with up to £5.1 million ($6.6 million USD) to support Ebola preparedness and prevention efforts in Uganda. This funding will support surveillance in high-risk districts at the border with the Democratic Republic of Congo (DRC); risk reduction communication in communities; infection prevention and control measures as well as provide for improved case management.” Peter Salama, WHO Emergency Response Chief, has noted that the outbreak could last another six months – “It’s very hard to predict timeframes in an outbreak as complicated as this with so many variables that are outside our control, but certainly we’re planning on at least another six months before we can declare this outbreak over,”.

ELBI Fellowship Application Opens
The Emerging Leader for Biosecurity Initiative (ELBI) run by the Center for Health Security is now accepting applications. This is a great opportunity that several Biodefense students have been able to take advantage of for the last several years. GMU Biodefense has had several fellows – Yong-Bee Lim  is currently an ELBI fellow and Saskia Popescu, Siddha Hover, and Francisco Cruz have represented our biodefense program in previous years. If you’re a current GMU biodefense student or alumni and are interested in applying and plan to request a letter of recommendation from the Biodefense program director, please do so ASAP. Dr. Koblentz asks that applicants send a copy of their application materials (personal statement, essay, and current resume or cv) and an unofficial GMU transcript by December 5, 2018.

 One Health in the 21st Century Workshop
The One Health in the 21st Century workshop will serve as a snapshot of government, intergovernmental organization and non-governmental organization innovation as it pertains to the expanding paradigm of One Health. One Health being the umbrella term for addressing animal, human, and environmental health issues as inextricably linked, each informing the other, rather than as distinct disciplines. This snapshot, facilitated by a partnership between the Wilson Center, World Bank, and EcoHealth Alliance, aims to bridge professional silos represented at the workshop to address the current gaps and future solutions in the operationalization and institutionalization of One Health across sectors. The workshop will be held on November 26th at the Wilson Center. You can RSVP here.

USDA ARS 5th International Biosafety & Biocontainment Symposium: Biorisk and Facility Challenges in Agriculture
Registration is open for this February 11, 2019 event! The symposium will provide 2.5 days of scientific presentations and exhibits regarding agricultural biosafety and biocontainment.

WHO Report on Surveillance of Antibiotic Consumption
The WHO has just released their report on global antibiotic consumption and the surveillance methods surrounding efforts to reduce antimicrobial resistance. “Since 2016, WHO has supported capacity building in monitoring antimicrobial consumption in 57 low- and middle-income countries through workshops, trainings and technical support. At this stage, 16 of these countries were able to share their national data with WHO. Other countries are currently in the process of data collection and validation.In total, 64 countries and Kosovo1 contributed data on antibiotic consumption for this report, with the bulk of data coming from the European region and countries with pre- existing, mature surveillance systems. The consumption data showed wide intra- and interregional variation in the total amount of antibiotics and the choice of antibiotics consumed. The overall consumption of antibiotics ranged from 4.4 to 64.4 DefinedDaily Doses (DDD) per 1000 inhabitants per day.”

Stories You May Have Missed:

  • Influenza Vaccine Efficacy Among Patients with High-Risk Medical Conditions in the U.S. – Researchers utilized data from the US Influenza Vaccine Effectiveness Network from 2012-2016 to analyze vaccine effectiveness (VE) “of standard-dose inactivated vaccines against medically-attended influenza among patients aged ≥6 months with and without high-risk medical conditions. Overall, 9643 (38%) of 25,369 patients enrolled during four influenza seasons had high-risk conditions; 2213 (23%) tested positive for influenza infection.Influenza vaccination provided protection against medically-attended influenza among patients with high-risk conditions, at levels approaching those observed among patients without high-risk conditions. Results from our analysis support recommendations of annual vaccination for patients with high-risk conditions.”

 

 

Pandora Report 7.6.2018

 

We hope you had a lovely holiday this week and are ready to get back into the world of biodefense! News is still unfolding regarding the two British citizens who were hospitalized after exposure to the nerve agent, Novichok, but we’ll keep you updated as more information becomes available.

Summer Biodefense Workshop – Pandemics, Bioterrorism, and Global Health Security
In less than two weeks the summer workshop on all things health security, from anthrax to Zika, will be taking place – are you registered? This three-day workshop will cover everything biodefense from the most recent Ebola outbreak, to DIY biohackers and vaccine development, and also the challenges of defending against biothreats. Speakers include experts in the field like David R. Franz, who was the chief inspector on three United Nations Special Commission biological warfare inspection missions to Iraq and served as technical advisor on long-term monitoring. His current standing committee appointments include the Department of Health and Human Services National Science Advisory Board for Biosecurity (NSABB), the National Academy of Sciences Committee on International Security and Arms Control, the National Research Council Board on Life Sciences, and the Senior Technical Advisory Committee of the National Biodefense Countermeasures Analysis Center. Jens H. Kuhn will also be speaking on filoviruses and what it was like to be the first western scientist with permission to work in a former Soviet biological warfare facility, SRCVB “Vektor” in Siberia, Russia, within the US Department of Defense’s Cooperative Threat Reduction (CTR) Program. These are just two of our speakers who will be leading discussions over the three days – come join the conversation at our workshop from July 18-20!

All Hands on Deck – U.S. Response to Ebola in West Africa
Princeton University’s Innovations for Successful Societies has just released their report on the quality of the U.S. response to Ebola. The case study is part of a series on Liberian response to the outbreak and includes great information on coordination, political response, and the challenges of international outbreak management. “Although the deployment, which scaled up earlier assistance, took place five months after the first reported cases and required extensive adaptation of standard practices, it succeeded in helping bring the epidemic under control: the total number of people infected—28,616—was well below the potential levels predicted by the CDC’s models. This US–focused case study highlights the challenges of making an interagency process work in the context of an infectious disease outbreak in areas where health systems are weak.”

Bats and Military Defense
Sure, your first inclination might be a vampire or Batman joke, but there’s actually a significant history regarding the U.S. military and utilization of these mammals. Historically, efforts focused on employing them as bombs in Japan but a more modern plan focuses on their uncanny ability to carry deadly diseases. “‘What we are trying to do is to study bat immunology, but that turned out to be a very difficult thing to do when starting from scratch,’ said Thomas Kepler, a professor of microbiology at Boston University. It took decades to create the reactive substances necessary to study human or mouse antibodies. With bats, he explained, they were starting from zero.” Battling potential Russian bioweapons means thinking outside of the box, right? The truth is that fruit bats have a pretty amazing weapon of their own – a super immunity that might just lend itself to curing Marburg and other devastating infections. “The Marburg virus is classed as a Category A bioterrorism agent by the Centers for Disease Control and Prevention, and Kepler’s study was supported by the Defense Threat Reduction Agency, a Defense Department division established during the Manhattan Project era to combat weapons of mass destruction. If the virus is ever deployed as biological warfare, the fruit bat’s super-immunity may hold the answer to preventing its spread. But it may also go some way toward redeeming the bat in the eyes of the U.S. military — and could even make the animal an unlikely hero.”

 NASPAA Pandemic Simulation
How would you handle a pandemic? GMU’s Schar School team qualified for the final round of the Network of Schools of Public Policy, Affairs, and Administration (NASPAA) pandemic simulation, in which student teams had to respond to a constantly evolving situation and make real-time decisions regarding quarantine, trade, etc. “‘The simulation is an especially valuable experience for the biodefense students since the pandemic crisis provided students with complex problems like those that they will tackle in their professional careers,’ said director of the Schar School’s biodefense graduate program, Gregory Koblentz. ‘These exercises also test the students’ ability to bridge the gap between the science and policy-making, a key goal of the biodefense programs’.”

Gene Editing – Last Week Tonight With John Oliver and How DARPA Wants to Boost Body Defense Through Gene Editing
This week’s episode of Last Week Tonight featured one of our favorite topics – gene editing! While there’s only so much you can cover in the span of 20 minutes, it was nice to see some of the complexities, personalities, and technical hurdles, covered by John Oliver. From biohackers to germline edits, Oliver mixed humor into a discussion on the very real issues surrounding gene editing technologies like CRISPR (although his version of the acronym is much more comical – Crunchy Rectums In Sassy Pink Ray-bans). Make sure to check out the episode to get a humorous overview on this gene-editing technology. Meanwhile, DARPA (the Defense Advanced Research Projects Agency) is actually working to harness gene editing to make your body’s natural defenses that much stronger through specific gene expressions. The project is called PREPARE (PReemptive Expression of Protective Alleles and Response Elements) and works to provide temporary boots to your natural defenses. “In contrast to recent gene-editing techniques, such as CRISPR, which focus on permanently changing the genome by cutting DNA and inserting new genes, the PREPARE program will concentrate on techniques that don’t make permanent changes to DNA. These techniques target the ‘epigenome,’ or the system that controls gene expression. Genes can be turned on or off by making external modifications to DNA, which don’t change the DNA sequence, but instead affect how cells ‘read’ genes. To start, the PREPARE program will focus on four key health challenges: influenza viral infection, opioid overdose, organophosphate poisoning (from chemicals in pesticides or nerve agents) and exposure to gamma radiation, the statement said.” While there are a lot of hurdles to overcome, the overall goal is to extend the platform to known and unknown threat application.

Improving Mass Casualty Management: The Role of Radiation Biodosimetry 
How would we handle the medical response of large-scale radiological exposure? GMU Biodefense PhD student Mary Sproull presented on this very topic and the work she and her team are doing, which is aimed at making testing more efficient and effective. “Drs. Sproull and Camphausen are working to make the medical management process more efficient and effective in the event of a mass casualty radiation exposure. Specifically, they are developing a dosimetry dose prediction model to determine how radiation biodosimetry diagnostics can help physicians estimate just how much radiation exposure a patient has experienced. (Radiation biodosimetry diagnostics estimate a person’s radiation exposure by measuring changes in biological markers that include cytogenic assays like dicentric chromosome assay.)”

Everything You Need to Know About Ricin
A few weeks back a Tunisian man was arrested by German police regarding suspected plans for a bioterrorism attack with ricin. German police were searching his residence in Cologne and found enough ricin for 1,000 toxic doses. During the fervor of the news, it was reported that such a a plot could have been more devastating than 9/11 – but what’s the reality behind ricin? Check out this comprehensive review of what ricin is (a naturally occurring biological poison), its history as a biological weapon and WMD, and more. “In summary, ricin’s status as a biological weapon is quite mixed. In terms of actual potential for harm, it is more at the level of knives than bombs. Its status as a WMD is a legal one, not so much a practical one. It would be useful to the public debate and our general social assessment of risk if the media could reflect this, rather than churn out hysterical reporting.”

Stories You May Have Missed:

  • VA Study Reveals Antibiotic Prescribing Habits – “A team of researchers establishing baseline data on antibiotic use by the Veterans Administration (VA) healthcare system in Pittsburgh found that about 75% of all antibiotic prescriptions were inappropriate, meaning they were either not indicated or were used for a duration that’s not recommended. The study, which took place over 12 months, looked at prescribing information, medical records, and charts of 40,734 patients, who were written 3,880 acute antibiotic prescriptions by 76 primary care providers (PCPs). The median antibiotic index was 84 antibiotic prescriptions per 1,000 patients per year.”
  • Drone Crashes Into French Nuclear Plant – “GREENPEACE activists say they have crashed a drone into a French nuclear plant to highlight the lack of security around the facility. The drone, which was decked out to resemble a tiny Superman, slammed into the tower in Bugey, 30 kilometers (20 miles) from the eastern city of Lyon, according to a video released Tuesday by Greenpeace. The environmental group says the drone was harmless but it showed the lax nuclear security in France, which is heavily dependent on nuclear power, using it for about 75 percent of its energy needs.”